DK148323B - ANALOGY PROCEDURE FOR PREPARING 1,3-DITHIOLANYL (2) - OR 1,3-DITHIANYL (2) COMPOUNDS - Google Patents

ANALOGY PROCEDURE FOR PREPARING 1,3-DITHIOLANYL (2) - OR 1,3-DITHIANYL (2) COMPOUNDS Download PDF

Info

Publication number
DK148323B
DK148323B DK668174AA DK668174A DK148323B DK 148323 B DK148323 B DK 148323B DK 668174A A DK668174A A DK 668174AA DK 668174 A DK668174 A DK 668174A DK 148323 B DK148323 B DK 148323B
Authority
DK
Denmark
Prior art keywords
dithian
general formula
methyl
compound
propylamine
Prior art date
Application number
DK668174AA
Other languages
Danish (da)
Other versions
DK668174A (en
DK148323C (en
Inventor
Henri Ramuz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK668174A publication Critical patent/DK668174A/da
Priority to DK11179A priority Critical patent/DK150486C/en
Publication of DK148323B publication Critical patent/DK148323B/en
Application granted granted Critical
Publication of DK148323C publication Critical patent/DK148323C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Description

148323148323

Den foreliggende opfindelse angår en analogifremgangsmåde til fremstilling af hidtil ukendte 1,3-dithiolanyl(2)- eller 1,3-dithianyl(2)--forbindeIser med den almene formel IThe present invention relates to an analogous process for the preparation of novel 1,3-dithiolanyl (2) or 1,3-dithianyl (2) compounds of the general formula I

x\ ^x 14 Åk r6 r - >c - y-N - (Z)m 1 R7 hvor R betegner en gruppe med den almene formel a eller b 2 Rl 148323 r3 eller a b 12 3 hvor R , R og R hver betegner hydrogen, halogen, lavere alkyl, lavere alkoxy, benzyloxy, phenyl, nitro, trifluormethyl, hydroxy, cyano, di-lavere alkylamino eller lavere alkanoyloxy eller to nabostillede grupper tilsammen betegner methylendioxy, ethylendioxy 4 eller butadien-l,3-ylen-l,4, R betegner hydrogen eller lavere al-5 6 7 kyl, R , R og R hver betegner hydrogen, halogen, lavere alkyl eller lavere alkoxy eller to nabostillede grupper sammen betegner ethylendioxy, X betegner svovl, SO eller SO2/ Y betegner en lige-kædet eller forgrenet, eventuelt hydroxysubstitueret aliphatisk carbonhydridkæde med 2-5 carbonatomer, Z betegner en ligekædet eller forgrenet, eventuelt hydroxysubstitueret aliphatisk carbonhydridkæde med 1-4 carbonatomer, m betegner 0 eller 1, og n betegner 2 eller 3, eller syreadditionssalte deraf.x \ ^ x 14 Ye r6 r -> c - yN - (Z) m 1 R7 where R represents a group of the general formula a or b 2 R 1 or ab 12 3 where R, R and R each represent hydrogen, halogen, lower alkyl, lower alkoxy, benzyloxy, phenyl, nitro, trifluoromethyl, hydroxy, cyano, di-lower alkylamino or lower alkanoyloxy or two adjacent groups together represent methylenedioxy, ethylenedioxy 4 or butadiene-1,3-ylene-1,4, R represents hydrogen or lower alkyl, R 6, R and R each represent hydrogen, halogen, lower alkyl or lower alkoxy or two adjacent groups together represent ethylenedioxy, X represents sulfur, SO or SO 2 / Y represents a straight chain or branched, optionally hydroxy-substituted aliphatic hydrocarbon chain of 2-5 carbon atoms, Z represents a straight or branched, optionally hydroxy-substituted aliphatic hydrocarbon chain of 1-4 carbon atoms, m represents 0 or 1, and n represents 2 or 3, or acid addition salts thereof.

Betegnelsen "lavere alkyl" angiver her en ligekædet eller forgrenet alkylgruppe med 1-6 carbonatomer såsom methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, text.butyl, amyl eller hexyl. "Lavere alkoxy" betegner en lavere alkylethergruppe, hvor betegnelsen "lavere alkyl" har den ovenfor angivne betydning. "Halogen" omfatter de fire halogenatomer fluor, chlor, brom og iod. "Lavere alka-noyl" betegner en lavere alkanoylgruppe med højst 6 carbonatomer såsom formyl, acetyl, propionyl eller butyryl. Den i det følgende anvendte betegnelse "udtrædende gruppe" angiver her kendte grupper såsom halogen, fortrinsvis brom eller chlor, arylsulfonyloxy såsom tosyloxy, alkylsulfonyloxy såsom mesyloxy eller epoxy.The term "lower alkyl" here denotes a straight or branched alkyl group having 1-6 carbon atoms such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, textbutyl, amyl or hexyl. "Lower alkoxy" means a lower alkyl ether group, the term "lower alkyl" having the meaning given above. "Halogen" includes the four halogen atoms fluorine, chlorine, bromine and iodine. "Lower alkanoyl" means a lower alkanoyl group having a maximum of 6 carbon atoms such as formyl, acetyl, propionyl or butyryl. The term "leaving group" as used herein denotes known groups such as halogen, preferably bromine or chlorine, arylsulfonyloxy such as tosyloxy, alkylsulfonyloxy such as mesyloxy or epoxy.

Fremgangsmåden ifølge den foreliggende opfindelse til fremstilling af forbindelser med den ovenfor angivne almene formel I eller salte deraf er ejendommelig ved, at 148323 3The process of the present invention for the preparation of compounds of the above general formula I or salts thereof is characterized in that:

a) en forbindelse med den almene formel II(a) a compound of general formula II

/(CIi2>n\/ (CIi2> n \

X XX X

R - C - Η IIR - C - Η II

hvor R, X og n hver har den ovenfor angivne betydning, omsættes med en forbindelse med den almene formel IIIwherein R, X and n are each as defined above are reacted with a compound of general formula III

4 r5 hvor R4 - R7, Y, Z og m hver har den ovenfor angivne betydning, og4 is R5 where R4 - R7, Y, Z and m each have the meaning given above, and

OISLAND

R betegner en udtrædende gruppe, ellerR represents a leaving group, or

b) en forbindelse med den almene formel IV(b) a compound of general formula IV

OR4 c I! ! /=VR5 h-c-y-n - (z)m—iv R7OR4 c I! ! / = VR5 h-c-y-n - (z) m-iv R7

hvor R, R4 - R7, Y, Z og m hver har den ovenfor angivne betydning, omsættes med en forbindelse med den almene formel Vwherein R, R4 - R7, Y, Z and m each have the meaning given above are reacted with a compound of the general formula V

HS - (CH2)n - SH VHS - (CH2) n - SH V

hvor n har den ovenfor angivne betydning, ellerwhere n has the meaning given above, or

c) en forbindelse med den almene formel VI(c) a compound of general formula VI

/(CH2>iN/ (CH2> iN

X XX X

\ X 8\ X 8

R - C - Y - R VIR - C - Y - R VI

148323 4148323 4

QQ

hvor R, R , X, Y og n hver har den ovenfor angivne betydning, omsættes med en forbindelse med den almene formel VIIwherein R, R, X, Y and n are each as defined above are reacted with a compound of general formula VII

r4 6 H - » - VI1 R7 4 7 hvor R - R , Z og m hver har den ovenfor angivne betydning, ellerr4 6 H - »- VI1 R7 4 7 wherein R - R, Z and m each have the meaning given above, or

d) en forbindelse med den almene formel Xd) a compound of general formula X

^m2K' R4 n x f^ m2K 'R4 n x f

R- C^Y-N-H XR-C ^ Y-N-H X

hvor R, R4, X, Y og n hver har den ovenfor angivne betydning, omsættes med en forbindelse med den almene formel XIwherein R, R4, X, Y and n are each as defined above are reacted with a compound of general formula XI

R5R5

r8 - <Z>m R XIr8 - <Z> m R XI

R7 hvor R^ - R®, Z og m hver har den ovenfor angivne betydning, ellerR7 wherein R 1 - R 2, Z and m each have the meaning given above, or

e) i en forbindelse med den almene formel XII eller XIIIe) in a compound of general formula XII or XIII

148323 5 /<CH2>S\ R4 f R X>C< Y1 - 1 - S1 ^ ‘‘ R7 R'4 r5 x\ / f° /hr r6148323 5 / <CH2> S \ R4 f R X> C <Y1 - 1 - S1 ^ '' R7 R'4 r5 x \ / f ° / hr r6

R - C - Y - H - (Z)m XIIIR - C - Y - H - (Z) m XIII

hvor R, R4 - R7, X, Y, Z, m og n hver har den ovenfor angivne betydning, Y^ og Ί?~ hver betegner henholdsvis Y og Z eller en tilsvarende oxosubstitueret gruppe, idet mindst én af grupperne og i 4 Z dog indeholder en carbonylgruppe, og R' betegner hydrogen eller en C-^-alkylgruppe, reduceres carbonylgruppen, hvorefter en fremstillet forbindelse med den almene formel I, hvor X betegner et svovlatom, om ønsket, oxideres til en forbindelse med den almene formel I, hvor X betegner SO eller S02, en fremstillet forbindelse 4 med den almene formel I, hvor R betegner hydrogen, om ønsket N-lavere alkyleres til en forbindelse med den almene formel I, hvor 4 R betegner C,_,-alkyl, en lavere alkoxy- eller benzyloxygruppe 1 2 3 for R , R eller R om ønsket omdannes til en hydroxygruppe, en 12 3 hydroxygruppe for R , R eller R om ønsket 0-lavere alkyleres eller forestres med en lavere alkancarboxylsyre, og en vunden base om ønsket omdannes til et syreadditionssalt.wherein R, R4 - R7, X, Y, Z, m and n each have the meaning given above, Y 1 and Ί? each represent Y and Z respectively or a corresponding oxo-substituted group, at least one of the groups and in 4 Z however, a carbonyl group contains and R 'represents hydrogen or a C 1-4 alkyl group, the carbonyl group is reduced, whereupon a compound of general formula I produced, wherein X represents a sulfur atom, if desired, is oxidized to a compound of general formula I, wherein X represents SO or SO2, a compound of formula 4 of general formula I wherein R represents hydrogen, if desired, N-lower is alkylated to a compound of general formula I wherein 4 R represents C1-6 alkyl, a lower alkoxy or benzyloxy group 1 2 3 for R, R or R if desired is converted to a hydroxy group, a 12 3 hydroxy group for R, R or R if desired is O-lower alkylated or esterified with a lower alkane carboxylic acid and a recovered base if desired is converted to an acid addition salt.

Som eksempler på foretrukne forbindelser med den almene formel I kan angives forbindelser med den almene formel la 6 148323 2 Rl .(CH2)n , R5 R v=k < /' * /4v *6 β_β-C - (CH2)3 - S - (CH2-CH2)m “ R3 R7 17 4 hvor R - R og m hver har den ovenfor angivne betydning, R" betegner methyl eller ethyl, og X^ betegner svovl eller SC^. Som eksempler på yderligere foretrukne forbindelser med den almene for- 1 2Examples of preferred compounds of general formula I may be mentioned compounds of general formula Ia (CH2) n, R5 R v = k </ '* / 4v * 6 β_β-C - (CH2) 3- S - (CH 2 -CH 2) m "R 3 R 7 17 4 wherein R - R and m each have the meaning given above, R" represents methyl or ethyl, and X 3 represents sulfur or SC 2. As examples of further preferred compounds with the general advantages 1 2

mel la kan angives forbindelser, i hvilke ét af symbolerne R , Rbetween compounds 1a may be indicated in which one of the symbols R, R

og R betegner hydrogen, og de andre betegner lavere alkoxy, især methoxy, eller sammen betegner butadien-l,3-ylen-l,4, eller to af symbolerne R , R^ og R betegner hydrogen, og det tredje betegner 5 6 7 nitro, og et af symbolerne R * R og R betegner hydrogen, og de to andre betegner lavere alkoxy, især methoxy. En særlig foretrukken forbindelse er N-(3,4-dimethoxyphenylethyl)-2-(3,4-dimethoxyphe-nyl)-N-methyl-m-dithian-2-propylamin-l,1,3,3-tetraoxid.and R represents hydrogen and the others represent lower alkoxy, especially methoxy, or together represent butadiene-1,3-ylene-1,4, or two of the symbols R, R 2 and R represent hydrogen, and the third represents 5 6 7 nitro, and one of the symbols R * R and R represents hydrogen and the other two represent lower alkoxy, especially methoxy. A particularly preferred compound is N- (3,4-dimethoxyphenylethyl) -2- (3,4-dimethoxyphenyl) -N-methyl-m-dithian-2-propylamine-1,3,3,3-tetraoxide.

Omsætningen af en forbindelse med den almene formel II med en forbindelse med den almene formel III udføres på i og for sig kendt måde. Omsætningen udføres hensigtsmæssigt i et under reaktionsbetingelserne inert, organisk opløsningsmiddel ved en temperatur mellem ca. -80eC og reaktionsblandingens tilbagesvalingstemperatur, fortrinsvis mellem ca. 0 og ca. 50°C, især omkring stuetemperatur. Som eksempler på opløsningsmidler kan angives ethere såsom di-ethylether, tetrahydrofuran eller dioxan, aromatiske carbonhydrider såsom benzen, toluen eller xylen, dimethylformamid eller dimethyl-sulfoxid. Omsætningen kan udføres i nærværelse af en stærk base såsom butyllithium, en Grignard-forbindelse, natrium eller natriumhydrid, idet der hensigtsmæssigt, såfremt X betegner svovl, anvendes en særlig stærk base såsom butyllithium eller en Grignard-forbindelse.The reaction of a compound of general formula II with a compound of general formula III is carried out in a manner known per se. The reaction is conveniently carried out in an organic solvent inert under the reaction conditions at a temperature between ca. -80 ° C and the reflux temperature of the reaction mixture, preferably between ca. 0 and approx. 50 ° C, especially around room temperature. Examples of solvents include ethers such as diethyl ether, tetrahydrofuran or dioxane, aromatic hydrocarbons such as benzene, toluene or xylene, dimethylformamide or dimethylsulfoxide. The reaction may be carried out in the presence of a strong base such as butyllithium, a Grignard compound, sodium or sodium hydride, suitably, where X represents sulfur, a particularly strong base such as butyllithium or a Grignard compound is used.

De som udgangsforbindelser anvendte forbindelser med de ovenfor angivne almene formler II og III er for en dels vedkommende kendte og for en dels vedkommende hidtil ukendte. De hidtil ukendte forbindelser kan fremstilles på i og for sig kendt måde, idet forbindelserne kan fremstilles analogt med fremstillingen af de kendte forbindelser.The compounds used as starting compounds of the above general formulas II and III are partly known and partly new. The novel compounds can be prepared in a manner known per se, the compounds being prepared analogously to the preparation of the known compounds.

148323 7148323 7

De forbindelser med den almene formel II, hvor X betegner svovl, kan f.eks. fremstilles ved omsætning af et aldehyd med den almene formel \h hvor R har den ovenfor angivne betydning, med ethan- eller propandi thiol. Omsætningen udføres hensigtsmæssigt i et inert organisk opløsningsmiddel, f.eks. chloroform, under stuetemperatur.The compounds of the general formula II wherein X represents sulfur may e.g. is prepared by reacting an aldehyde of the general formula \ h wherein R is as defined above with ethane or propane thiol. The reaction is conveniently carried out in an inert organic solvent, e.g. chloroform, below room temperature.

De forbindelser med den almene formel II, hvor X betegner SO eller SO2, kan fremstilles ved oxidation af de tilsvarende forbindelser, hvor X betegner svovl. Oxidationen kan hensigtsmæssigt udføres i et egnet opløsningsmiddel under anvendelse af persyrer, såsom pereddikesyre, perphthaisyre eller m-chlorperbenzoesyre. Pereddikesyre kan f.eks. dannes in situ ud fra iseddike og hydrogenperoxid.The compounds of general formula II wherein X represents SO or SO2 can be prepared by oxidation of the corresponding compounds where X represents sulfur. The oxidation may conveniently be carried out in a suitable solvent using peracids such as peracetic acid, perphthalic acid or m-chloroperbenzoic acid. Peracetic acid may e.g. is formed in situ from glacial acetic acid and hydrogen peroxide.

Omsætningen af en forbindelse med den almene formel IV med en forbindelse med den almene' formel V udføres på i og for sig kendt måde. Omsætningen udføres hensigtsmæssigt i et under reaktionsbetingelserne inert, organisk opløsningsmiddel, fortrinsvis i et polært opløsningsmiddel såsom halogenerede carbonhydrider, f.eks. chloroform eller methylenchlorid eller i ethylenglycoldimethylether. Omsætningen udføres også hensigtsmæssigt i nærværelse af et vand-fraspaltende middel såsom svovlsyre, hydrogenhalogenidsyrer, eller phosphorsyre ved en temperatur mellem ca. 0°C og reaktionsblandingens tilbagesvalingstemperatur, fortrinsvis ved stuetemperatur.The reaction of a compound of general formula IV with a compound of general formula V is carried out in a manner known per se. The reaction is conveniently carried out in an inert organic solvent under the reaction conditions, preferably in a polar solvent such as halogenated hydrocarbons, e.g. chloroform or methylene chloride or in ethylene glycol dimethyl ether. The reaction is also conveniently carried out in the presence of a water-scavenging agent such as sulfuric acid, hydrogen halide acids, or phosphoric acid at a temperature between 0 ° C and the reflux temperature of the reaction mixture, preferably at room temperature.

De som udgangsforbindelser anvendte forbindelser med den almene formel V er kendte og kan fremstilles på kendt måde.The starting compounds of general formula V are known and can be prepared in known manner.

De som udgangsforbindelser anvendte forbindelser med den almene formel IV er hidtil ukendte.The compounds of the general formula IV used as starting compounds are novel.

Forbindelser med den almene formel IV kan f.eks. fremstilles ved, at en forbindelse med den almene formel XIVa 8 148323Compounds of general formula IV may, for example, is prepared by a compound of general formula XIVa 8 148323

OISLAND

R - C - Y - Cl XIVaR - C - Y - Cl XIVa

hvor R og Y hver har den ovenfor angivne betydning, omsættes med en forbindelse med den almene formel VIIwherein R and Y each have the meaning given above are reacted with a compound of general formula VII

4 r5 H - " - (Z)m VI1 R7 4 7 hvor R - R , Z og nt hver har den ovenfor angivne betydning.4 r5 H - "- (Z) m VI1 R7 4 7 where R - R, Z and nt each have the meaning given above.

Omsætningen udføres hensigtsmæssigt i nærværelse af et syrebindende middel såsom en tertiær amin, f.eks. N-ethyl-N,N-diisopropylamin, der samtidig kan udgøre opløsningsmidlet. Omsætningen udføres også hensigtsmæssigt ved forhøjet temperatur, fortrinsvis ved en temperatur indtil ca. 130°C, afhængigt af opløsningsmidlet kogetemperatur.The reaction is conveniently carried out in the presence of an acid-binding agent such as a tertiary amine, e.g. N-ethyl-N, N-diisopropylamine, which may simultaneously constitute the solvent. The reaction is also conveniently carried out at elevated temperature, preferably at a temperature up to approx. 130 ° C, depending on the solvent boiling temperature.

De ovenfor anvendte forbindelser med den almene formel XIVa er for en dels vedkommende kendte og for en dels vedkommende hidtil ukendte. Forbindelserne kan fremstilles på i og for sig kendt måde, f.eks. analogt med fremstillingen af de kendte forbindelser. Forbindelser med den almene formel VII er kendte.The above-used compounds of the general formula XIVa are partly known and partly new. The compounds may be prepared in a manner known per se, e.g. analogous to the preparation of the known compounds. Compounds of general formula VII are known.

Omsætningen af en forbindelse med den almene formel VI med en forbindelse med den almene formel VII udføres på i og for sig kendt måde. Omsætningen udføres hensigtsmæssigt i et under reaktionsbetingelserne inert organisk opløsningsmiddel såsom en ether, f.eks. dibutylether, dioxan eller tetrahydrofuran, en alkanol såsom ethanol eller propanol, et aromatisk carbonhydrid såsom benzen, toluen eller xylen eller i acetonitril, dimethylformamid eller dimethyl-sulfoxid. Omsætningen kan udføres ved en temperatur mellem ca. stuetemperatur og reaktionsblandingens tilbagesvalingstemperatur. Omsætningen udføres fortrinsvis ved tilbagesvalingstemperaturen. Såfremt der fraspaltes syre ved omsætningen, udføres denne hensigtsmæssigt 9 148323 i nærværelse af en base, f.eks. en tertiær amin såsom trimethylamin, N-ethyl-N,N-diisopropylamin eller N,N-dimethylanilin.The reaction of a compound of general formula VI with a compound of general formula VII is carried out in a manner known per se. The reaction is conveniently carried out in an organic solvent inert under the reaction conditions such as an ether, e.g. dibutyl ether, dioxane or tetrahydrofuran, an alkanol such as ethanol or propanol, an aromatic hydrocarbon such as benzene, toluene or xylene or in acetonitrile, dimethylformamide or dimethylsulfoxide. The reaction can be carried out at a temperature between approx. room temperature and the reflux temperature of the reaction mixture. The reaction is preferably carried out at the reflux temperature. If acid is cleaved off by reaction, it is conveniently carried out in the presence of a base, e.g. a tertiary amine such as trimethylamine, N-ethyl-N, N-diisopropylamine or N, N-dimethylaniline.

De som udgangsforbindelser anvendte forbindelser med den almene formel VII er kendte. Forbindelser med den almene formel VI er hidtil ukendte. Forbindelser med den almene formel VI kan f.eks. fremstilles ved, at en forbindelse med den almene formel XIVThe compounds of general formula VII used as starting compounds are known. Compounds of general formula VI are novel. Compounds of general formula VI may e.g. is prepared by a compound of general formula XIV

00

Il 8Il 8

R - C - Y - R° XIVR - C - Y - R ° XIV

QQ

hvor R, R og Y hver har den ovenfor angivne betydning, omsættes med en forbindelse med den almene formel Vwherein R, R and Y each have the meaning given above are reacted with a compound of general formula V

HS " (CH2}n " SfI VHS "(CH2} n" SfI V

hvor n har den ovenfor angivne betydning, og en vunden forbindelse med den almene formel VI, hvor X betegner svovl, om ønsket ved oxidation omdannes til en forbindelse med den almene formel VI, hvor X betegner SO eller S02.where n has the meaning given above and a won compound of the general formula VI, where X represents sulfur, if desired by oxidation is converted to a compound of the general formula VI where X represents SO or SO2.

Omsætningen af en forbindelse med den almene formel XIV med en forbindelse med den almene formel V kan udføres på i og for sig kendt måde. Omsætningen udføres hensigtsmæssigt i et under reaktionsbe-tingelseme inert, organisk opløsningsmiddel, fortrinsvis i et polært opløsningsmiddel såsom halogenerede carbonhydrider, f.eks. chloroform eller methylenchlorid, eller i ethylenglycoldimethylether.The reaction of a compound of general formula XIV with a compound of general formula V can be carried out in a manner known per se. The reaction is conveniently carried out in an inert organic solvent under the reaction conditions, preferably in a polar solvent such as halogenated hydrocarbons, e.g. chloroform or methylene chloride, or in ethylene glycol dimethyl ether.

Omsætningen udføres også hensigtsmæssigt i nærværelse af et vand-fraspaltende middel såsom svovlsyre, hydrogenhalogenidsyrer eller phosphorsyre ved en temperatur mellem ca. 0°C og reaktionsblandingens tilbagesvalingstemperatur, fortrinsvis ved stuetemperatur.The reaction is also conveniently carried out in the presence of a water-scavenging agent such as sulfuric acid, hydrogen halide or phosphoric acid at a temperature between 0 ° C and the reflux temperature of the reaction mixture, preferably at room temperature.

Omdannelsen af en vunden forbindelse med den almene formel VI, hvor X betegner svovl, til en forbindelse, hvor X betegner SO eller S02, kan udføres på i og for sig kendt måde, f.eks. ved oxidation med en persyre, f.eks. pereddikesyre, perphthalsyre eller m-chlorper-benzoesyre. Pereddikesyre kan f.eks. dannes in situ ud fra iseddike og hydrogenperoxid.The conversion of a won compound of the general formula VI, where X represents sulfur, to a compound where X represents SO or SO2 can be carried out in a manner known per se, e.g. by oxidation with a peracid, e.g. peracetic acid, perphthalic acid or m-chloroperbenzoic acid. Peracetic acid may e.g. is formed in situ from glacial acetic acid and hydrogen peroxide.

ίο 148323ίο 148323

Omsætningen af en forbindelse med den almene formel X med en forbindelse med den almene formel XI udføres på i og for sig kendt måde. Omsætningen udføres hensigtsmæssigt i et under reaktionsbetingelserne inert, organisk opløsningsmiddel såsom en ether, f.eks. di-butylether, dioxan eller tetrahydrofuran, en alkanol, f.eks. ethanol eller propanol, et aromatisk carbonhydrid, f.eks. benzen, toluen eller xylen, eller i acetonitril, dimethylformamid eller dimethyl-sulfoxid. Omsætningen kan udføres ved en temperatur mellem ca. stuetemperatur og reaktionsblandingens tilbagesvalingstemperatur. Omsætningen udføres fortrinsvis ved tilbagesvalingstemperaturen. Såfremt der fraspaltes syre ved omsætningen, udføres denne hensigtsmæssigt i nærværelse af en base, f.eks. en tertiær amin såsom triethylamin, N-éthyl-N,N-diisopropylamin eller N,N-dimethylanilin.The reaction of a compound of general formula X with a compound of general formula XI is carried out in a manner known per se. The reaction is conveniently carried out in an organic solvent inert under the reaction conditions such as an ether, e.g. dibutyl ether, dioxane or tetrahydrofuran, an alkanol, e.g. ethanol or propanol, an aromatic hydrocarbon, e.g. benzene, toluene or xylene, or in acetonitrile, dimethylformamide or dimethylsulfoxide. The reaction can be carried out at a temperature between approx. room temperature and the reflux temperature of the reaction mixture. The reaction is preferably carried out at the reflux temperature. If acid is cleaved off by reaction, it is conveniently carried out in the presence of a base, e.g. a tertiary amine such as triethylamine, N-ethyl-N, N-diisopropylamine or N, N-dimethylaniline.

De som udgangsforbindeiser anvendte forbindelser med den almene formel XI er kendte. Forbindelser med den almene formel X er hidtil ukendte. Forbindelser med den almene formel X kan f.eks. fremstilles ved, at en forbindelse med den almene formel ViaThe compounds used as starting compounds of the general formula XI are known. Compounds of general formula X are novel. Compounds of the general formula X is produced by a compound of the general formula Via

X XX X

R Y - Cl ViaR Y - Cl Via

hvor R, X, Y og n hver har den ovenfor angivne betydning, omsættes med en forbindelse med den almene formel XVIwherein R, X, Y and n are each as defined above are reacted with a compound of general formula XVI

R4 - NH2 XVIR4 - NH2 XVI

4 hvor R har den ovenfor angivne betydning. Da der herved fraspaltes hydrogenchlorid, udføres omsætningen hensigtsmæssigt i nærværelse af en base eller under anvendelse af et overskud af aminen med den almene formel XVI. Omsætningen kan endvidere udføres analogt med omsætningen af en forbindelse med den almene formel VI med en forbindelse med den almene formel VII.4 where R has the meaning given above. Since hydrogen chloride is thereby decomposed, the reaction is conveniently carried out in the presence of a base or using an excess of the amine of the general formula XVI. Furthermore, the reaction can be carried out analogously to the reaction of a compound of the general formula VI with a compound of the general formula VII.

148323 11148323 11

Forbindelser med den almene formel XVI er kendte. Forbindelser med den almene formel Via, der for en dels vedkommende er hidtil ukendte, kan fremstilles analogt med fremstillingen af forbindelser med den almene formel VI.Compounds of general formula XVI are known. Compounds of general formula Via, which are, to some extent, novel, can be prepared analogously to the preparation of compounds of general formula VI.

Reduktionen af en carbonylgruppe i en forbindelse med den almene formel XII eller XIII udføres på i og for sig kendt måde.The reduction of a carbonyl group in a compound of general formula XII or XIII is carried out in a manner known per se.

Et amid med den almene formel XII eller XIII, dvs. en forbindelse, i hvilken carbonylgruppen er direkte bundet til nitrogenatomet, kan således reduceres ved behandling med metalhydrider såsom lithium-aluminiumhydrid eller diisobutylaluminiumhydrid eller diboran. Dette udføres hensigtsmæssigt i et under reaktionsbetingelserne inert organisk opløsningsmiddel såsom ethere, f.eks. diethylether eller tetrahydrofuran, eller i diglyme ved en temperatur mellem ca. 0°C og reaktionsblandingens tilbagesvalingstemperatur, fortrinsvis omkring stuetemperatur.An amide of the general formula XII or XIII, i.e. Thus, a compound in which the carbonyl group is directly bonded to the nitrogen atom can be reduced by treatment with metal hydrides such as lithium aluminum hydride or diisobutyl aluminum hydride or diborane. This is conveniently carried out in an organic solvent inert under the reaction conditions such as ethers, e.g. diethyl ether or tetrahydrofuran, or in diglyme at a temperature between ca. 0 ° C and the reflux temperature of the reaction mixture, preferably about room temperature.

Reduktionen af andre carbonylgrupper, dvs. sådanne, der ikke er bundet direkte til nitrogenatomet, udføres ligeledes på i og for sig kendt måde. Reduktionen kan især udføres således, at der enten dannes den tilsvarende hydroxymethylengruppe, som derefter reduceres videre til methylengruppen, eller der direkte dannes methylen-gruppen.The reduction of other carbonyl groups, viz. those not directly bonded to the nitrogen atom are also carried out in a manner known per se. In particular, the reduction can be carried out so that either the corresponding hydroxymethylene group is formed, which is then reduced further to the methylene group or the methylene group is formed directly.

Reduktionen til en hydroxymethylengruppe kan udføres ved behandling med et complext metalhydrid såsom et alkalimetalaluminiumhydrid eller et alkalimetalborhydrid.The reduction to a hydroxymethylene group can be accomplished by treatment with a complex metal hydride such as an alkali metal aluminum hydride or an alkali metal borohydride.

Reduktionen under anvendelse af et alkalimetalaluminiumhydrid eller et alkalimetalborhydrid kan hensigtsmæssigt udføres ved stuetemperatur eller ved en temperatur over eller under stuetemperatur i et inert organisk opløsningsmiddel. Som eksempler på egnede opløsningsmidler til reduktionen med et alkalimetalaluminiumhydrid kan angives vandfri ethere såsom diethylether eller tetrahydrofuran, og ved reduktionen med et alkalimetalborhydrid kan anvendes alkanoler med 1-4 carbonatomer såsom methanol eller ethanol eller dioxan. Som alkalimetalaluminiumhydrid anvendes fortrinsvis lithiumaluminiumhydrid, og som alkalimetalborhydrid anvendes natriumborhydrid.The reduction using an alkali metal aluminum hydride or an alkali metal borohydride may conveniently be carried out at room temperature or at or above room temperature in an inert organic solvent. Examples of suitable solvents for the reduction with an alkali metal aluminum hydride may be given anhydrous ethers such as diethyl ether or tetrahydrofuran, and the reduction with an alkali metal borohydride may be used alkanols of 1-4 carbon atoms such as methanol or ethanol or dioxane. Preferably, lithium aluminum hydride is used as alkali metal aluminum hydride and sodium borohydride is used as alkali metal borohydride.

148323 12148323 12

Den videre reduktion af en hydroxymethylengruppe til en methylengruppe udføres på i og for sig kendt måde, især ved omdannelse til den tilsvarende sulfonsyreester eller til halogenidet og reduktion af denne eller dette med complexe metalhydrider. Reduktionen kan udføres analogt med den ovenfor beskrevne reduktion af carbonyl-grupper.The further reduction of a hydroxymethylene group to a methylene group is carried out in a manner known per se, especially by conversion to the corresponding sulfonic acid ester or to the halide and reduction thereof or complex metal hydrides. The reduction can be carried out by analogy with the reduction of carbonyl groups described above.

Den direkte reduktion af en carbonylgruppe til en methylengruppe kan udføres på i og for sig kendt måde under anvendelse af en Wolff-Kisn-ner-reduktion, dvs. ved omsætning af ketonen med hydrazin til fremstilling af den tilsvarende hydrazon og sønderdeling af hydrazonen under basiske betingelser.The direct reduction of a carbonyl group to a methylene group can be carried out in a manner known per se using a Wolff-Kisnner reduction, ie. by reacting the ketone with hydrazine to prepare the corresponding hydrazone and decomposing the hydrazone under basic conditions.

De som udgangsforbindelser anvendte forbindelser med den almene formel XII og XIII er hidtil ukendte forbindelser.The compounds used as starting compounds of general formulas XII and XIII are novel compounds.

Amider med den almene formel XII kan f.eks. fremstilles ved, at enFor example, amides of general formula XII may be used. is produced by the fact that one

syre med den almene formel XVIIacid of general formula XVII

7<α,2>»\7 <α, 2> '\

R - c - Y - cr XVIIR - c - Y - cr XVII

\\

OHOH

hvor R, Y, X og n hver har den ovenfor angivne betydning, omsættes med en amin med den almene formel VIIwherein R, Y, X and n are each as defined above are reacted with an amine of the general formula VII

R4 R5 h " (i)-"ér 4 7 hvor R - R , Z og m hver har den ovenfor angivne betydning. Omsætningen kan hensigtsmæssigt udføres i nærværelse af en tertiær ami n såsom triethylamin og en halogencarboxylsyreester såsom chlormyre-syreisobutylester (blandet anhydridmetode) i et inert organisk opløsningsmiddel, f.eks. tetrahydrofuran, ved en temperatur mellem ca.R4 R5 h "(i) -" is 4 7 where R - R, Z and m each have the meaning given above. The reaction may conveniently be carried out in the presence of a tertiary amine such as triethylamine and a halogenated carboxylic acid ester such as chloroformic acid isobutyl ester (mixed anhydride method) in an inert organic solvent, e.g. tetrahydrofuran, at a temperature between ca.

0 og ca. 30°C.0 and approx. 30 ° C.

148323 13148323 13

Forbindelser med den almene formel XVII kan fremstilles analogt med den ovenfor beskrevne fremstilling af forbindelser med den almene formel VI ud fra forbindelser med den almene formel XVIIICompounds of general formula XVII can be prepared analogously to the preparation of compounds of general formula VI described above from compounds of general formula XVIII

00

IlIl

R - C - Y - CR - C - Y - C

\\

OHOH

hvor R og Y hver har den ovenfor angivne betydning. Forbindelser med den almene formel XVIII tilhører en kendt forbindelsesklasse.wherein R and Y each have the meaning given above. Compounds of general formula XVIII belong to a known compound class.

Ketoner med den almene formel XII kan fremstilles på i og for sig kendt måde, f.eks. ved oxidation af de tilsvarende alkoholer. Oxidationen kan f.eks. udføres med complexet chromtrioxid/pyridin i py-ridin ved en temperatur mellem ca. -20°C og ca. stuetemperatur, fortrinsvis ved ca. 0°C.Ketones of general formula XII can be prepared in a manner known per se, e.g. by oxidation of the corresponding alcohols. The oxidation may e.g. is carried out with complex chromium trioxide / pyridine in pyridine at a temperature between ca. -20 ° C and approx. room temperature, preferably at approx. 0 ° C.

Fremstillingen af amider med den almene formel XIII kan udføres på i og for sig kendt måde, f.eks. ved acylering af en forbindelse med den almene formel I, hvor R4 betegner hydrogen. Acyleringen kan f.eks. udføres med et halogenid af en lavere carboxylsyre i en tertiær amin, f.eks. pyridin, ved en tenperatur mellem ca. 0 og ca.The preparation of amides of general formula XIII can be carried out in a manner known per se, e.g. by acylating a compound of general formula I wherein R 4 represents hydrogen. The acylation may e.g. is carried out with a halide of a lower carboxylic acid in a tertiary amine, e.g. pyridine, at a temperature between ca. 0 and approx.

30°C, fortrinsvis omkring stuetemperatur-.30 ° C, preferably about room temperature.

Omdannelsen af en forbindelse med den almene formel I, hvor X betegner svovl, til en forbindelse, hvor x betegner SO eller S02, kan udføres ved oxidation i et egnet opløsningsmiddel under anvendelse af persyrer såsom pereddikesyre, perphthalsyre eller m-chlorperben-zoesyre. Pereddikesyre kan f.eks. fremstilles in situ ud fra iseddike og hydrogenperoxid.The conversion of a compound of general formula I wherein X represents sulfur to a compound where x represents SO or SO2 can be accomplished by oxidation in a suitable solvent using peracids such as peracetic acid, perphthalic acid or m-chloroperbenzoic acid. Peracetic acid may e.g. are prepared in situ from glacial acetic acid and hydrogen peroxide.

44

Resulterende forbindelser med den almene formel I, hvor R betegner hydrogen, kan alkyleres på i og for sig kendt måde, f.eks. under anvendelse af lavere alkylhalogenider. De pågældende forbindelser omsættes herved hensigtsmæssigt umiddelbart med alkylhalogenidet ved lavere temperatur.Resulting compounds of general formula I wherein R represents hydrogen may be alkylated in a manner known per se, e.g. using lower alkyl halides. Consequently, the compounds concerned are reacted immediately with the alkyl halide at lower temperature.

Omdannelsen af en lavere alkoxy- eller benzyloxygruppe til en hydroxygruppe udføres på i og for sig kendt måde, f.eks. ved 148323 14 opvarmning med en koncentreret hydrogenhalogenidsyre, især konstant kogende brombr·' n^esyreThe conversion of a lower alkoxy or benzyloxy group to a hydroxy group is carried out in a manner known per se, e.g. heating with a concentrated hydrogen halide acid, especially constant boiling bromine

Forethringen eller forestringen af en tilstedeværende hydroxygruppe udføres på i og for sig kendt måde, f.eks. ved omsætning af et tilsvarende halogenid, f.eks. med et tilsvarende syrehalogenid eller en syreanhydrid.The etherification or esterification of a hydroxy group present is carried out in a manner known per se, e.g. by reacting a corresponding halide, e.g. with a corresponding acid halide or acid anhydride.

Forbindelser med.den almene formel I kan omdannes til syreadditionssalte , f.eks. ved behandling med en uorganisk syre såsom en hydrogenhalogenidsyre, f.eks. saltsyre eller brombrintesyre, svovlsyre eller phosphorsyre eller med en organisk syre såsom oxalsyre, vinsyre, citronsyre eller methansulfonsyre. Blandt syreadditionssalte af forbindelser med den almene formel I foretrækkes farmaceutisk anvendelige forbindelser. Såfremt der ved fremgangsmåden ifølge den foreliggende opfindelse fås et syreadditionssalt af en forbindelse med den almene formel I, kan et sådant salt på i og for sig kendt måde, f.eks. ved behandling med alkali, omdannes til den frie base, og denne kan om ønsket omdannes til et andet syreadditionssalt.Compounds of general formula I can be converted to acid addition salts, e.g. by treatment with an inorganic acid such as a hydrogen halide acid, e.g. hydrochloric or hydrobromic, sulfuric or phosphoric or with an organic acid such as oxalic, tartaric, citric or methanesulfonic. Among the acid addition salts of compounds of general formula I, pharmaceutically useful compounds are preferred. If, by the process of the present invention, an acid addition salt is obtained from a compound of the general formula I, such a salt may be known per se, e.g. upon treatment with alkali, it is converted to the free base and, if desired, can be converted to another acid addition salt.

De forbindelser med den almene formel I, som indeholder et asymmetrisk carbonatom, kan foreligge i racemisk eller i optisk aktiv form, og den foreliggende opfindelse angår en fremgangsmåde til fremstilling af såvel de racemiske som de optisk aktive former. Et racemat kan på i og for sig kendt måde, f.eks. ved fraktioneret krystallisation af de tilsvarende salte med en optisk aktiv syre, om ønsket opspaltes i de optiske antipoder.The compounds of the general formula I which contain an asymmetric carbon atom can be in racemic or optically active form, and the present invention relates to a process for preparing both the racemic and optically active forms. A racemate can be known in a manner known per se, e.g. by fractional crystallization of the corresponding salts with an optically active acid, if desired, split into the optical antipodes.

Forbindelser med den almene formel I og syreadditionssalte deraf har værdifulde coronardilaterende egenskaber og kan bl.a. anvendes til behandling af angina pectoris.Compounds of general formula I and their acid addition salts have valuable coronary dilating properties. used to treat angina pectoris.

Den eoronardilaterende virkning kan bestemmes under anvendelse af følgende metode:The eoronardilating effect can be determined using the following method:

Til undersøgelsen anvendes bastardhunde med en vægt på 20 - 38 kg. Forsøgsdyrene narkotiseres med ca. 30 mg/kg pentcbarbital intravenøst, og narkosen opretholdes med chloralose-urethan. Dyrene får 148323 15 kunstigt åndedræt med lokalets luft. Efter åbning af thorax gøres der åbent ind til hjertet, og rundt om den venstre coronarartenes Ramus circumflexus lægges en forud justeret "Flow"-føler fra et elektromagnetisk "Flowmeter" til bestemmelse af den gennemstrømmende blodmængde. Vandopløselige præparater appliceres intravenøst opløst i en isotonisk kogsaltopløsning, og vanduopløselige præparater appliceres intravenøst i propylenglycol. Et præparats maksimale virkning beregnes efter hver dosering i procent af udgangsværdien og afbildes grafisk. Ved bestemmelse af coronargennemblødningen tages der især også hensyn til virkningstiden.For the study, bastard dogs weighing 20 - 38 kg are used. The test animals are anesthetized by approx. 30 mg / kg pentcbarbital intravenously and the anesthetic is maintained with chloralose-urethane. The animals receive artificial respiration with the air of the room. After opening the thorax, the heart is opened and around the left coronary artery's Ramus circumflexus a pre-adjusted "Flow" sensor is placed from an electromagnetic "Flowmeter" to determine the flow of blood. Water-soluble preparations are applied intravenously dissolved in an isotonic saline solution, and water-insoluble preparations are applied intravenously in propylene glycol. The maximum effect of a preparation is calculated after each dosing as a percentage of the initial value and graphed. In determining coronary hemorrhage, the duration of action is particularly taken into account.

Fra de tyske fremlæggelsesskrifter nr. 1.154.810 og nr. 2.000.435 kendes forbindelser med lignende struktur. De ved fremgangsmåden ifølge opfindelsen fremstillede forbindelser adskiller sig imidlertid væsentligt fra de kendte forbindelser, især ved at indeholde gruppenConnections with a similar structure are known from the German disclosures 1,154,810 and 2,000,435. However, the compounds of the process according to the invention differ substantially from the known compounds, in particular by containing the group

X XX X

\ / - c - hvori n og X har ovennævnte betydning, i stedet for gruppen\ / - c - wherein n and X have the above meaning, instead of the group

C=NC = N

- C - H1' hvor R-*-1 er en carbonhydridgruppe. Fra nævnte fremlæggelsesskrifter kan bl.a. nævnes den forbindelse, der er bedst kendt under navnet Verapamil, nemlig 5-[(3,4-dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitril-hydrochlorid, såvel som det tilsvarende ethylendioxyderivat a-isopropyl-a-[(N-methyl-N-homoveratryl)-γ-aminopropyl]-3,4-ethylendioxyphenylacetonitril, der ligeledes som calciumantagonister har coronardilaterende egenskaber. Forbindelserne fremstillet ved fremgangsmåden ifølge opfindelsen bevirker dog en højere maksimal coronargennemblødningsstigning end de kendte forbindelser, der endvidere også er belastet med en stærk og 148323 16 længe virkende hypotensiv og negativ-inotrop virkning, altså med bivirkninger, der kan virke negativt. Til forskel herfra har de ved fremgangsmåden ifølge opfindelsen fremstillede forbindelser ikke disse negative egenskaber, men udviser tværtimod gode antiarrhytmiske egenskaber ved god tolerabilitet.- C - H1 'where R - * - 1 is a hydrocarbon group. From the present writings, inter alia, mentioned is the compound best known by the name of Verapamil, namely 5 - [(3,4-dimethoxyphenethyl) methylamino] -2- (3,4-dimethoxyphenyl) -2-isopropylvaleronitrile hydrochloride, as well as the corresponding ethylenedioxy derivative α-isopropyl -a - [(N-methyl-N-homoveratryl) -γ-aminopropyl] -3,4-ethylenedioxyphenylacetonitrile, which also, as calcium antagonists, has coronardilating properties. However, the compounds produced by the method of the invention cause a higher maximal coronary hemorrhage increase than the known compounds, which are also loaded with a strong and long-acting hypotensive and negative-inotropic effect, that is, with adverse effects which may be negative. In contrast, the compounds prepared by the process of the invention do not have these negative properties but, on the contrary, exhibit good antiarrhythmic properties at good tolerability.

I følgende tabel er der anført virkningsmaksima for en række forbindelser fremstillet ved fremgangsmåden ifølge opfindelsen samt for den kendte forbindelse Verapamil.The following table lists the efficacy maxima for a number of compounds prepared by the process of the invention as well as for the known compound Verapamil.

TabelTable

Forbindelse Maksimal coronargennem- Dosis, mg blødningsstigning , % intravenøst N-(3,4-Dimethoxyphenethyl)--N-methyl-3[2-(m-methoxy-phenyl) -m-dithian-2-yl] - propylamin-hydrochlorid 133 ‘ 1 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2^(3,4,5-trimeth-oxyphenyl)-m-dithian-2-yl]- propylamin-hydrochlorid 140 1 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-(p-methoxy-phenyl)-m-dithian^-2-yl]- propylamin-hydrochlorid 223 1 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-(o-methoxy-phenyl)-m-dithian-2-yl]- propylamin-hydrochlorid 172 1 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-(p-chlorphe-nyl)-m-dithian-2-yl]propylamin-hydrochlorid 172 1 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-phenyl-m-di-thian-2-yl]-propylamin-hydrochlorid 241 3 148323 17Compound Maximum Coronary Transmission Dose, mg bleeding increase,% intravenous N- (3,4-Dimethoxyphenethyl) - N-methyl-3 [2- (m-methoxy-phenyl) -m-dithian-2-yl] - propylamine hydrochloride 133 '1 N- (3,4-dimethoxyphenethyl) -N-methyl-3 [2β (3,4,5-trimethoxyphenyl) -m-dithian-2-yl] propylamine hydrochloride 140 (3,4-dimethoxyphenethyl) - N-methyl-3 [2- (p-methoxy-phenyl) -m-dithian-2-yl] -propylamine hydrochloride 223 L N- (3,4-dimethoxyphenethyl) - -N-methyl-3 [2- (o-methoxy-phenyl) -m-dithian-2-yl] -propylamine hydrochloride 172 L N- (3,4-dimethoxyphenethyl) - N-methyl-3 [2- (p-chlorophenyl) -m-dithian-2-yl] propylamine hydrochloride 172 1 N- (3,4-dimethoxyphenethyl) - N-methyl-3 [2-phenyl-m-diethian-2 yl] propylamine hydrochloride 17

Tabel fortsat N-(p-chlorphenethyl)-N-methyl--3[2-phenyl-m-dithian-2-yl]-propylamin-1,1,3,3-tetraoxid- -hydrochlorid 132 1 N-(p-chlorphenethyl)-N-methyl--3[2-phenyl-m-dithian-2-yl]- propylamin-hydrochlorid 210 3 N-methyl-N-phenethyl-3[2-phe-ny1-m-dithian-2-y1]propylamin-hydrochlorid 155 3 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-(3,4-methylen-dioxyphenyl)-m-dithian-2- -yl]propylamin-hydrochlorid 145 1 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-(p-tolyl)-m--dithian-2-yl]propylamin- -hydrochlorid 130 1 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-(3,5-dimetho-xyphenyl)-m-dithian-2-yl]- propylamin-D-tartrat 145 1 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-(2-naphthyl)--m-dithian-2-y1]propylamin- -hydrochlorid 213 1 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-(p-fluorphe-nyl)-m-dithian-2-y1]propylamin-hydrochlorid 153 1 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-(m-bromphe-nyl)-m-dithian-2-y1]propylamin-1 , 1,3,3-tetraoxid- -hydrochlorid 185 0,3 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-(3,4-methy-lendioxyphenyl)-m-dithian--2-y1]propylamin-1,1,3,3- -tetraoxid-hydrochlorid 130 3 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-(p-tolyl)-m--dithian-2-yl]propylamin--1,1,3,3-tetraoxid-hydro- chlorid 290 3 148323 18Table continued N- (p-chlorophenethyl) -N-methyl-3 [2-phenyl-m-dithian-2-yl] -propylamine-1,1,3,3-tetraoxide hydrochloride 132 1 N- (p -chlorophenethyl) -N-methyl - 3 [2-phenyl-m-dithian-2-yl] -propylamine hydrochloride 210 3 N-methyl-N-phenethyl-3 [2-phe-ny1-m-dithian-2 -Y1] propylamine hydrochloride 155 3 N- (3,4-dimethoxyphenethyl) - N-methyl-3 [2- (3,4-methylene-dioxyphenyl) -m-dithian-2-yl] propylamine hydrochloride 145 1 N- (3,4-dimethoxyphenethyl) - N-methyl-3 [2- (p-tolyl) -methithian-2-yl] propylamine hydrochloride 130 1 N- (3,4-dimethoxyphenethyl) - N-methyl-3 [2- (3,5-dimethoxy-phenyl) -m-dithian-2-yl] -propylamine-D-tartrate 145 L N- (3,4-dimethoxyphenethyl) -N-methyl -3 [2- (2-naphthyl) - m -dithian-2-yl] propylamine hydrochloride 213 1 N- (3,4-dimethoxyphenethyl) - N-methyl-3 [2- (p-fluorophenyl) Nyl) -m-dithian-2-yl] propylamine hydrochloride 153 1 N- (3,4-dimethoxyphenethyl) -N-methyl-3 [2- (m-bromophenyl) -m-dithian-2-yl ] propylamine-1,3,3-tetraoxide hydrochloride 185 0.3 N- (3,4-dimethoxyphenethyl) -N-methyl-3 [2- (3,4-methylenedio] xyphenyl) -m-dithian-2-yl] propylamine-1,1,3,3- tetraoxide hydrochloride 130 3 N- (3,4-dimethoxyphenethyl) -N-methyl-3 [2- (p tolyl) -m-dithian-2-yl] propylamine - 1,1,3,3-tetraoxide hydrochloride 290 3

Tabel fortsat N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-(m-nitrophe-nyl)-m-dithian-2-yl]propylamin-1 ,1,3,3-tetraoxid- -hydrochlorid 202 1 N- (3,4-dimethoxyphenethyl)--N-methyl-3[2-phenyl-m-di-thian-2-yl]ethylamin-hydro- chlorid 182 3 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-[p-(dimeth-ylamino)-phenyl ] -m-dithian- -2-yl]propylamin-hydrochlorid 130 3 rac.-a-/[(3,4-dimethoxyphenethyl) -methylaminolmethy.l/--2-(3,4-dimethoxyphenyl)--m-dithian-2-ethanol-D- -tartrat 140 3 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-(3,4-dimethoxyphenyl) -m-dithian-2-yl]- pentylamin-D-tartrat 208 3 N- (3,4-dimethoxyphenethyl)--N-methyl-3[2-(3,4-dimethoxyphenyl) -m-dithian-2-yl]- propylamin-hydrochlorid 138 1 N-(3,4-dimethoxyphenethyl)--N-methyl-3[2-(3,4-dimethoxyphenyl) -m-dithian-2-yl]-propylamin-1,1,3,3-tetra- oxid-hydrochlorid 230 3 N- (3,4-dimethoxyphenethyl)--N-ethyl-3[2-(3,4-dimethoxyphenyl) -m-dithian-2-yl]-propylamin-1,1,3,3-tetra- oxid-hydrochlorid 267 3 5-[(3,4-dimethoxyphenethyl)-methylamino]-2-(3,4-dimeth-oxyphenyl)-2-isopropylvale-ronitri1-hydrochlorid (Verapamil) 128 0,3 148323 19Table continued N- (3,4-Dimethoxyphenethyl) -N-methyl-3 [2- (m-nitrophenyl) -m-dithian-2-yl] propylamine-1,3,3-tetraoxide- hydrochloride 202 1 N- (3,4-dimethoxyphenethyl) - N-methyl-3 [2-phenyl-m-di-thian-2-yl] ethylamine hydrochloride 182 3 N- (3,4-dimethoxyphenethyl) - N-methyl-3 [2- [p- (dimethylamino) phenyl] -m-dithian-2-yl] propylamine hydrochloride 130. rac.-a - / [(3,4-dimethoxyphenethyl) -methylaminolmethyl-2- (3,4-dimethoxyphenyl) - m -dithian-2-ethanol-D-tartrate 140 3 N- (3,4-dimethoxyphenethyl) - N-methyl-3 [2 - (3,4-dimethoxyphenyl) -m-dithian-2-yl] - pentylamine-D-tartrate 208 3 N- (3,4-dimethoxyphenethyl) - N-methyl-3 [2- (3,4-dimethoxyphenyl) ) -m-dithian-2-yl] propylamine hydrochloride 138 1 N- (3,4-dimethoxyphenethyl) - N-methyl-3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl ] -propylamine-1,1,3,3-tetraoxide hydrochloride 230 3 N- (3,4-dimethoxyphenethyl) -N-ethyl-3 [2- (3,4-dimethoxyphenyl) m -dithian 2-yl] -propylamine-1,1,3,3-tetra-oxide hydrochloride 267 3 - [(3,4-dimethoxyphenethyl) methylamino] -2- (3,4- dimethoxyphenyl) -2-isopropylvalonitrile hydrochloride (Verapamil) 128 0.3

De ved fremgangsmåden ifølge opfindelsen fremstillede forbindelser og farmaceutisk anvendelige syreadditionssalte deraf kan som lægemidler anvendes i form af farmaceutiske præparater, som indeholder disse forbindelser i blanding med et til enteral eller parenteral applikation egnet farmaceutisk, organisk eller uorganisk inert bærestof såsom vand, gelatine, gummi arabicum, lactose, stivelse, magnesiums tearat, talkum, vegetabilske olier, polyalkylenglycoler eller vaseline. De farmaceutiske præparater kan foreligge i fast form, f.eks. i form af tabletter, dragéer eller kapsler, eller i flydende form, f.eks. i opløsninger, suspensioner eller emulsioner. Præparaterne er eventuelt steriliserede og/eller indeholder hjælpestoffer såsom konserverings-, stabiliserings-, befugtnings- eller emulgeringsmidler, salte til ændring af det osmotiske tryk eller pufferstoffer.The compounds of the invention and pharmaceutically useful acid addition salts thereof can be used as pharmaceuticals in the form of pharmaceutical compositions containing these compounds in admixture with a pharmaceutical, organic or inorganic inert carrier suitable for enteral or parenteral application, such as water, gelatin, gum arabic , lactose, starch, magnesium tearate, talc, vegetable oils, polyalkylene glycols or vaseline. The pharmaceutical compositions may be in solid form, e.g. in the form of tablets, dragees or capsules, or in liquid form, e.g. in solutions, suspensions or emulsions. The compositions are optionally sterilized and / or contain adjuvants such as preservatives, stabilizers, wetting or emulsifying agents, salts for changing the osmotic pressure or buffers.

Den daglige dosis ved oral administration er mellem ca. 10 og 200 mg og ved intravenøs administration mellem ca. 1 og 20 mg.The daily dose of oral administration is between approx. 10 and 200 mg and by intravenous administration between ca. 1 and 20 mg.

De angivne doseringer skal dog kun opfattes som eksempler og kan ændres afhængigt af sværhedsgraden af det tilfælde, som skal behandles, og afhængigt af den behandlende læges vurdering.However, the dosages indicated should only be construed as examples and may change depending on the severity of the case to be treated and on the basis of the treating physician's judgment.

Fremgangsmåden ifølge opfindelsen belyses nærmere ved de følgende eksempler, mens de følgende fremstillinger illustrerer udgangsmaterialers fremstilling.The process of the invention is illustrated in more detail by the following examples, while the following preparations illustrate the preparation of starting materials.

Fremstilling 1.Preparation 1.

74,7 g 3,4-dimethoxybenzaldehyd opløses i 1250 ml chloroform, der tilsættes 50 ml 1,3-propandithiol og afkøles under omrøring ved 0°C. Der tilsættes 20 ml bortrifluoridetherat, og reaktionsblandingen lades henstå i 18 timer i køleskab. Derefter vaskes blandingen tre gange successivt med 500 ml af en 7%'s kaliumhydroxidopløsning og 500 ml af en 10%'s natriumchloridopløsning. De organiske ekstrakter forenes, tørres med magnesiumsulfat og inddampes. Remanensen omkrystalliseres to gange af ether. Der fås 102,6 g 2-(3,4-di-methoxyphenyl)-m-dithian med smeltepunkt 99 - 101"C.74.7 g of 3,4-dimethoxybenzaldehyde are dissolved in 1250 ml of chloroform, 50 ml of 1,3-propanedithiol is added and cooled with stirring at 0 ° C. 20 ml of boron trifluoride etherate are added and the reaction mixture is allowed to stand for 18 hours in a refrigerator. The mixture is then washed three times successively with 500 ml of a 7% potassium hydroxide solution and 500 ml of a 10% sodium chloride solution. The organic extracts are combined, dried with magnesium sulfate and evaporated. The residue is recrystallized twice by ether. 102.6 g of 2- (3,4-di-methoxyphenyl) -m-dithian are obtained, mp 99-101 ° C.

148323 20148323 20

De følgende dithianer kan fremstilles på analog måde: 2-(o-methoxyphenyl)-m-dithian med smeltepunkt 126 - 127°C (af CH2C12/ isopropylether), 2-phenyl-m-dithian med smeltepunkt 72 - 73°C ( af CH2Cl2/isopropyl-ether), 2-(p-chlorphenyl)-m-dithian med smeltepunkt 87 - 88eC (af GH2C12/ isopropylether), 2-(m-methoxyphenyl)-m-dithian med smeltepunkt 62 - 63°C (af isopropylether) , 2-(3,4,5-trimethoxyphenyl)-m-dithian med smeltepunkt 88 - 89 ° C (af CH2Cl2/isopropylether), 2-(m-chlorphenyl)-m-dithian med smeltepunkt 63 - 64°C (af cyclohe-xan) , 2-(3,5-dimethoxyphenyl)-m-dithian med smeltepunkt 90 - 91°C (af cyclohexan), p-(m-dithian-2-yl)-Ν,Ν-dimethylanilin med smeltepunkt 118 - 119“C (af cyclohexan), 2-(m-nitrophenyl)-m-dithian med smeltepunkt 117 - 118°C (af CH2C12/ methanol), 2-(3,4-methylendioxyphenyl)-m-dithian med smeltepunkt 86 - 87°C (af cyclohexan), 2-p-tolyl-m-dithian med smeltepunkt 89 - 90°C (af ether/hexan), 2-(m-bromphenyl)-m-dithian med smeltepunkt 78 - 79°C (af cyclohexan), 2-(2-naphthyl)-m-dithian med smeltepunkt 110 - 111°C (af cyclohexan), 2-(2,4,5-trimethoxyphenyl)-m-dithian med smeltepunkt 156 - 157eC (af Cl^Cl^/methanol) , 2-(p-fluorphenyl)-m-dithian med smeltepunkt 105 - 106'C (af cyclohexan) , 2-(4-biphenylyl)-m-dithian med smeltepunkt 148 - 151'C (af tetrahydro-furan/cyclohexan), 2-(α,α,α-trifluor-p-tolyl)-m-dithian med smeltepunkt 103 - 104eC (af cyclohexan), 2-(1-naphthyl)-m-dithian med smeltepunkt 147 - 148°C (af cyclohexan), 2-(3-benzyloxy-4-methoxyphenyl)-m-dithian med smeltepunkt 168 -170°C (af cyclohexan), 2-(4-benzyloxy-3-methoxyphenyl)-m-dithian med smeltepunkt 118 - 119°C (af cyclohexan), 148323 21 2-(2-thienyl)-m-dithian med smeltepunkt 74 - 75eC (af cyclohexan), 2-(α,α,α-trifluor-m-tolyl)-m-dithian med smeltepunkt 69 - 71®C (af heptan), 2-(p-isopropylphenyl)-m-dithian med smeltepunkt 58 - 59®C (af hexan), 2-(3,4-xylyl)-m-dithian med kogepunkt 74 - 75°C (af petroleums-ether), 2-(3-butoxy-4-irøthoxyphenyl)-m-dii±ian med smeltepunkt 72 - 73°C (af cyclohexan), 2-(4-ethoxy-3-methoxyphenyl)-m-dithian med kogepunkt 88 - 90°C (af methylenchlorid og isopropylether), m-(m-dithian-2-yl)-benzonitril med kogepunkt 84 - 86°C (af isopropylether) , 6-m-dithian-2-y1-1,4-benzodioxan med kogepunkt 140 - 142®C (af methylenchlorid og isopropylether) og 2-(4-methoxy-m-tolyl)-m-dithian med kogepunkt 75 - 77°C (af cyclohexan) .The following dithians can be prepared in an analogous manner: 2- (o-methoxyphenyl) -m-dithian, m.p. 126 - 127 ° C (of CH 2 Cl 2 / isopropyl ether), 2-phenyl-m-dithian, m.p. 72 - 73 ° C (of CH2 Cl2 / isopropyl ether), 2- (p-chlorophenyl) -m-dithian, m.p. 87-88 ° C (of GH2C12 / isopropyl ether), 2- (m-methoxyphenyl) -m-dithian, mp 62-63 ° C (of isopropyl ether), 2- (3,4,5-trimethoxyphenyl) -m-dithian, m.p. 88 - 89 ° C (of CH 2 Cl 2 / isopropyl ether), 2- (m-chlorophenyl) -m-dithian, m.p. 63 - 64 ° C (of cyclohexane), 2- (3,5-dimethoxyphenyl) -m-dithian, m.p. 90-191 ° C (of cyclohexane), p- (m-dithian-2-yl) -Ν, Ν-dimethylaniline with mp 118 - 119 ° C (of cyclohexane), 2- (m-nitrophenyl) -m-dithian with mp 117-118 ° C (of CH 2 Cl 2 / methanol), 2- (3,4-methylenedioxyphenyl) -m-dithian with m.p. 86 - 87 ° C (of cyclohexane), 2-p-tolyl-m-dithian, m.p. 89-90 ° C (of ether / hexane), 2- (m-bromophenyl) -m-dithian, m.p. 78 - 79 ° C (of cyclohexane), 2- ( 2-naphthyl) -m-dithian, m.p. 110-111 ° C (of cyclohexane), 2- (2,4,5-trimethoxyphenyl) -m-dithian, mp 156-157 ° C (of Cl 2 Cl 2 / methanol), 2- (p-fluorophenyl) -m-dithian with melting point 105 - 106 ° C (of cyclohexane), 2- (4-biphenylyl) -m-dithian of melting point 148 - 151 ° C (of tetrahydrofuran / cyclohexane), 2- (α, α, α-trifluoro-p-tolyl) -m-dithian with melting point 103 - 104 ° C (of cyclohexane), 2- (1-naphthyl) -m-dithian of melting point 147 - 148 ° C (of cyclohexane) ), 2- (3-benzyloxy-4-methoxyphenyl) -m-dithian, m.p. 168-170 ° C (of cyclohexane), 2- (4-benzyloxy-3-methoxyphenyl) -m-dithian, m.p. 118-199 ° C (of cyclohexane), 2- (2-thienyl) -m-dithian, m.p. 74 - 75 ° C (of cyclohexane), 2- (α, α, α-trifluoro-m-tolyl) -m-dithian, m.p. 69-71 ° C (of heptane), 2- (p-isopropylphenyl) -m-dithian with m.p. 58-59 ° C (of hexane), 2- (3,4-xylyl) -m-dithian of boiling point 74 - 75 ° C (of petroleum ether), 2- (3-butoxy-4-erothoxyphenyl) -midienyl, m.p. 72-73 ° C (of cyclohexane), 2- (4-ethoxy-3-methoxyphenyl) -m-dithian with boiling point 88 - 90 ° C (of methylene chloride and isopropyl ether), m- (m-dithian-2-yl) -benzonitrile with bp 84 - 86 ° C (of isopropyl ether), 6-m-dithian-2-yl -1,4-benzodioxane with boiling point 140 - 142 ° C (of methylene chloride and isopropyl ether) and 2- (4-methoxy-m-tolyl) ) -m-dithian with boiling point 75 - 77 ° C (of cyclohexane).

Fremstilling 2.Preparation 2.

60 g 2-(3,4-dimethoxyphenyl)-m-dithian (fremstillet ifølge fremstilling 1) opløses i 470 ml iseddike, og ved stuetemperatur tilsættes 235 ml 30%'s hydrogenperoxid, hvorved opløsningens temperatur stiger indtil ca. 40°C. Opløsningen lades henstå natten over ved stuetemperatur. Derefter opvarmes blandingen i 2 timer ved 100°C. Efter afkøling til stuetemperatur frafiltreres det krystallinske bundfald, som vaskes med iseddike, tørres natten over i vakuum ved 60"C og derefter omkrystalliseres af acetonitril. Der fås 57,1 g 2-(3,4-dimethoxyphenyl)--m-dithian-1,1,3,3-tetraoxid med smeltepunkt 243 - 245°C.60 g of 2- (3,4-dimethoxyphenyl) -m-dithian (prepared according to Preparation 1) are dissolved in 470 ml of glacial acetic acid and at room temperature 235 ml of 30% hydrogen peroxide are added, raising the temperature of the solution to approx. 40 ° C. The solution is left to stand overnight at room temperature. The mixture is then heated for 2 hours at 100 ° C. After cooling to room temperature, the crystalline precipitate which is washed with glacial acetic acid is filtered off, dried overnight in vacuo at 60 ° C and then recrystallized from acetonitrile. 57.1 g of 2- (3,4-dimethoxyphenyl) m -dithian 1,1,3,3-tetraoxide, mp 243 - 245 ° C.

De følgende dithiolano- og dithianotetraoxider kan fremstilles analogt med den ovenfor beskrevne fremgangsmåde: 2-(m-bromphenyl)-m-dithian-1,1,3,4-tetraoxid med smeltepunkt 230 -231°C (af acetonitril), 2-(p-fluorphenyl)-m-dithian-1,1,3,3-tetraoxid med smeltepunkt 283 -284°C (af acetonitril), 2-(m-nitrophenyl)-m-dithian-1,1,3,3-tetraoxid med smeltepunkt 256 -257°C (af acetonitril), 2-(3,4,5-trimethoxyphenyl)-m-dithian-1,1,3,3-tetraoxid med smeltepunkt 148323 22 >310°C (af acetonitril), 2-(2-naphthyl)-m-dithian-1,1,3,3-tetraoxid med smeltepunkt 277 -278°C (af acetone/acetonitril), 2-p-tolyl-m-dithian-1,1,3,3-tetraoxid med smeltepunkt 284 - 285°C (af acetonitril), 2-(4-benzyloxy-3-methoxyphenyl)-m-dithian-1,1,3,3-tetraoxid med smeltepunkt 220 - 223°C (af acetone/acetonitril), 2-(3,4-dimethoxyphenyl)-1,3-dithiolan-l,1,3,3-tetraoxid med smeltepunkt 194 - 196°C (af acetone/acetonitril), 2-(3,4-methylendioxyphenyl)-m-dithian-1,1,3,3-tetraoxid med smeltepunkt '* 300,eC (af acetone/acetonitril), 2-(2*-thienyl)-m-dithian-1,1,3,3-tetraoxid med smeltepunkt >300*C (af acetone/acetonitril), 2-(3,4-dichlorphenyl)-m-dithian-1,1,3,3-tetraoxid med smeltepunkt 254 - 255eC (af iseddike/vand), 2-(a, a,a-trifluor-m-tolyl)-m-dithian-1,1,3,3-tetraoxid med smeltepunkt 239 - 242°C (af iseddike/vand), 2-(p-isopropylphenyl)-m-dithian-1,1,3,3-tetraoxid med smeltepunkt 204 - 205‘"C (af acetonitril/ethanol) , 2-(3,4-xylyl)-m-dithian-1,1,3,3-tetraoxid med smeltepunkt 268 -269°C (af acetonitril og methanol), 2-(3-butoxy-4-methoxyphenyl)-m-dithian-1,1,3,3-tetraoxid med smeltepunkt 225 - 227°C (af iseddike/vand), 2-(4-ethoxy-3-methoxyphenyl)-m-dithian-1,1,3,3-tetraoxid med smeltepunkt 242 - 244°C (af acetone/acetonitril), m- (m-dithian- 2' -y 1) -benzonitril-1 ^1^3^31 -tetraoxid med smeltepunkt 259 - 260"C (af iseddike/vand), 6-m-dithian-2,-yl-l,4-benzodioxan-l',1',3',3'-tetraoxid med smeltepunkt 232°C sønderdelihg (af iseddike/vand) og 2-(4-methoxy-m-tolyl)-m-dithian-11,1',31,3'-tetraoxid med smeltepunkt 225 - 221° Q, (af iseddike/vand) .The following dithiolano and dithianotetra oxides may be prepared by analogy to the procedure described above: 2- (m-bromophenyl) -m-dithian-1,1,3,4-tetraoxide, mp 230-231 ° C (of acetonitrile), 2- (p-fluorophenyl) -m-dithian-1,1,3,3-tetraoxide, mp 283 -284 ° C (of acetonitrile), 2- (m-nitrophenyl) -m-dithian-1,1,3,3 -tetra oxide, m.p. 256 -257 ° C (of acetonitrile), 2- (3,4,5-trimethoxyphenyl) -m-dithian-1,1,3,3-tetraoxide, mp> 310 ° C (of acetonitrile) ), 2- (2-naphthyl) -m-dithian-1,1,3,3-tetraoxide, m.p. 277 -278 ° C (of acetone / acetonitrile), 2-p-tolyl-m-dithian-1.1 , 3,3-tetraoxide, m.p. 284 - 285 ° C (of acetonitrile), 2- (4-benzyloxy-3-methoxyphenyl) -m-dithian-1,1,3,3-tetraoxide, mp 220 - 223 ° C (of acetone / acetonitrile), 2- (3,4-dimethoxyphenyl) -1,3-dithiolane-1,3,3-tetraoxide, m.p. 194 - 196 ° C (of acetone / acetonitrile), 2- (3 4-methylenedioxyphenyl) -m-dithian-1,1,3,3-tetraoxide, m.p. 300, eC (of acetone / acetonitrile) , 2- (2 * -thienyl) -m-dithian-1,1,3,3-tetraoxide, m.p.> 300 ° C (of acetone / acetonitrile), 2- (3,4-dichlorophenyl) -m-dithian 1,1,3,3-tetraoxide, m.p. 254 - 255 ° C (of glacial acetic acid / water), 2- (a, a, α-trifluoro-m-tolyl) -m-dithian-1,1,3,3-tetraoxide m.p. 239 - 242 ° C (of glacial acetic acid / water), 2- (p-isopropylphenyl) -m-dithian-1,1,3,3-tetraoxide, mp 204-205 ° C (of acetonitrile / ethanol), 2- (3,4-xylyl) -m-dithian-1,1,3,3-tetraoxide, mp 268 -269 ° C (of acetonitrile and methanol), 2- (3-butoxy-4-methoxyphenyl) -m -dithian-1,1,3,3-tetraoxide, mp 225 - 227 ° C (of glacial acetic acid / water), 2- (4-ethoxy-3-methoxyphenyl) -m-dithian-1,1,3,3- tetraoxide, m.p. 242 - 244 ° C (of acetone / acetonitrile), m- (m-dithian-2'-yl) -benzonitrile-1 ^ 1 ^ 3 ^ 31 -tetra oxide, mp 259-260 ° C (of glacial acetic acid) / water), 6-m-dithian-2, -yl-1,4-benzodioxane-1 ', 1', 3 ', 3'-tetraoxide, mp 232 ° C decomp. (of glacial acetic acid / water) and 2- ( 4-Methoxy-m-tolyl) -m-dithian-11,1 ', 31,3'-tetraoxide with melt sections 225 - 221 ° Q, (of glacial acetic acid / water).

Eksempel 1.Example 1.

I en sulfoneringskolbe afkøles under tilledning af argon 19,2 g 2-(3,4-dimethoxyphenyl)-m-dithian (fremstillet ifølge fremstilling 1) og 200 ml tetrahydrofuran til -60°C, og der tilsættes langsomt 33 ml butyllithium i hexan. Derefter omrørés blandingen i 2 timer ved -20°C.In a sulphonation flask, with argon, 19.2 g of 2- (3,4-dimethoxyphenyl) -m-dithian (prepared according to Preparation 1) and 200 ml of tetrahydrofuran are cooled to -60 ° C and 33 ml of butyl lithium in hexane are slowly added. . Then the mixture is stirred for 2 hours at -20 ° C.

148323 23 I løbet af 15 minutter tildryppes ved -70eC en opløsning af 18 g N-(3-chlorpropyl)-N-methyl-3,4-dimethoxy-phenylethylamin i 200 ml tetrahydrofuran. Blandingen lades derefter henstå i 18 timer ved -20°C i en dybfryser og i 3 timer ved stuetemperatur. Reaktionsopløsningen hældes derefter på vand og ekstraheres tre gange med ether.Within 15 minutes, a solution of 18 g of N- (3-chloropropyl) -N-methyl-3,4-dimethoxy-phenylethylamine in 200 ml of tetrahydrofuran is added dropwise at -70 ° C. The mixture is then allowed to stand for 18 hours at -20 ° C in a freezer and for 3 hours at room temperature. The reaction solution is then poured onto water and extracted three times with ether.

De etheriske ekstrakter ekstraheres derefter tre gange med 250 ml IN saltsyre. Til de sure ekstrakter sættes 3N natriumhydroxidopløsning indtil en pH-værdi over 12, og den udskilte olie ekstraheres med ether. De organiske ekstrakter tørres med magnesiumsulfat og inddampes. Den resulterende olie (30 g) opløses i ethylacetat, og der tilsættes etherisk HBr. Det udfældede bundfald omkrystalliseres af ethanol. Der fås N- (3,4-dimethoxyphenylethyl) -iJ-methyl-3 [2- (3,4-dimethoxyphenyl) --m-dithian-2-yl]propylamin-hydrobromid med smeltepunkt 170 - 172°C.The ethereal extracts are then extracted three times with 250 ml of 1N hydrochloric acid. To the acidic extracts is added 3N sodium hydroxide solution to a pH above 12 and the separated oil is extracted with ether. The organic extracts are dried over magnesium sulfate and evaporated. The resulting oil (30 g) is dissolved in ethyl acetate and ethereal HBr is added. The precipitated precipitate is recrystallized from ethanol. N- (3,4-dimethoxyphenylethyl) -1H-methyl-3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propylamine hydrobromide is obtained, mp 170 DEG-172 DEG.

Analyse:Analysis:

Beregnet for C2gH37N04S2-HBr: C 54,54 H 6,69 N 2,45 Br 13,95Calculated for C₂2H37NNO4S₂-HBr: C 54.54 H 6.69 N 2.45 Br 13.95

Fundet: C 54,54 H 6,74 N 2,31 Br 14,05Found: C 54.54 H 6.74 N 2.31 Br 14.05

Det som udgangsforbindelse anvendte N-(3-chlorpropyl)-N-methyl-3,4-di-methoxy-phenylethylamin kan fremstilles på følgende måde: 292,5 g N-methylhomoveratrylamin opløses i 1000 ml dimethylformamid, og der tilsættes 415 g vandfrit kaliumcarbonat. Blandingen omrøres ved 5°C, der tilsættes 237 g 1,3-bromchlorpropan i 500 ml dimethyl-formamid, og blandingen omrøres i 4 timer ved stuetemperatur og hældes derefter på 6 liter vand. Den udskilte olie ekstraheres tre gange med hver gang 2 liter ether. De organiske ekstrakter tørres med magnesiumsulfat og inddampes i vakuum. Den resulterende olie destilleres ved en temperatur mellem 69 og 70°C ved 0,005 mm Hg under anvendelse af en kviksølvdiffusionspumpe. Der fås 206,7 g N-(3-chlorpropyl)-N-methy1-3,4-dimethoxy-phenylethylamin med kogepunkt 69 - 70*C/ 0,005 mm Hg.The starting N- (3-chloropropyl) -N-methyl-3,4-dimethoxy-phenylethylamine used as the starting compound can be prepared as follows: Dissolve 292.5 g of N-methylhomoveratrylamine in 1000 ml of dimethylformamide and add 415 g of anhydrous potassium carbonate. The mixture is stirred at 5 ° C, 237 g of 1,3-bromochloropropane is added in 500 ml of dimethylformamide and the mixture is stirred for 4 hours at room temperature and then poured into 6 liters of water. The separated oil is extracted three times with 2 liters of ether each time. The organic extracts are dried over magnesium sulfate and evaporated in vacuo. The resulting oil is distilled at a temperature between 69 and 70 ° C at 0.005 mm Hg using a mercury diffusion pump. 206.7 g of N- (3-chloropropyl) -N-methyl-3,4-dimethoxy-phenylethylamine are obtained at boiling point 69-70 ° C / 0.005 mm Hg.

De følgende forbindelser kan fremstilles analogt med den ovenfor beskrevne fremgangsmåde: N- (3,4-dimethoxyphenylethyl)-N-methyl-3 [2- (m-methoxyphenyl) - m-dithian--2-yl]propylamin-hydrochlorid med smeltepunkt 113 - 115°C (af acetone).The following compounds can be prepared analogously to the procedure described above: N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (m-methoxyphenyl) - m -dithian-2-yl] propylamine hydrochloride, m.p. 113 - 115 ° C (of acetone).

148323 24 N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(3,4,5-trimethoxyphenyl)--m-dithian-2-yl]propylamin-hydrochlorid med smeltepunkt 147 - 150°C (af acetone), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(p-methoxyphenyl)-m-di-thian-2-yl]propylamin-hydrochlorid med smeltepunkt 160 - 161°C (af acetone), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(o-methoxyphenyl)-m-di-thian-2-yl]propylamin-hydrochlorid med smeltepunkt 151 - 152°C (af acetone), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(p-chlorphenyl)-m-di-. thian-2-yl]propylamin-hydrochlorid med smeltepunkt 137 - 139°C (af acetone), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-phenyl-m-dithian-2-yl]-propylamin-hydrochlorid med smeltepunkt 170 - 172°C (af acetone), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(3,4-methylendioxyphenyl)--m-dithian-2-ylJpropylamin-hydrochlorid med smeltepunkt 139 - 141°C (af acetone), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(p-tolyl)-m-dithian-2-yl]-propylamin-hydrochlorid med smeltepunkt 139 - 141°C (af acetone), N-(3,4-dimethoxyphenylethyl)-N-methyl-m-3[2-(m-chlorphenyl) -m-dithian--2-yl]propylamin-hydrochlorid med smeltepunkt 108 - 110°C (af acetone), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(3,5-dimethoxyphenyl)--m-dithian-2-yl]propylamin-oxalat (1:1) med smeltepunkt 155 - 156"C (af acetone), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(p-dimethylaminopheny1)--m-dithian-2-yl]propylamin-hydrochlorid med smeltepunkt 183 - 184°C (af acetone), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(2,4,5-trimethoxyphenyl)--m-dithian-2-yl]propylamin-hydrochlorid med smeltepunkt 156 - 158eC (af acetone), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(p-fluorphenyl)-m-di-thian-2-yl]propylamin-hydrochlorid med smeltepunkt 138 - 139eC (af acetone), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(4-biphenylyl)-m-di-thian-2-yl]propylamin-oxalat (1:1) med smeltepunkt 167 - 169"C (af acetone), 148323 25 N-(p-chlorphenylethyl)-N-methyl-3[2-phenyl-m-dithian-2-yl]-propylamin-hydrochlorid med smeltepunkt 145 - 147 "C (af acetone), ud fra 2-phenyl-m-dithian og N-(3-chlorpropyl)-N-methyl-4-chlor-phenylethylamin, N-methyl-N-phenylethyl-3[2-phenyl-m-dithian-2-yl]propylamin-hydrochlorid med smeltepunkt 136 - 137°C (af acetone) ud fra 2-phenyl--m-dithian~og N-(3-chlorphenyl)-N-methylphenylethylamin (kogepunkt 78 - 80eC/0,001 mm Hg), N-(3,4-dimethoxyphenylethyl)-N-methyl-2[2-phenyl-m-dithian-2-yl]-ethylamin-hydrochlorid med smeltepunkt 172 - 174"C (af acetone) ud fra 2-phenyl-m-dithian og N-(2-chlorethyl)-3,4-dimethoxy-N--methylphenylethylamin, N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(2-thienyl)-m-dithian-2-yl]-propylamin-hydrochlorid med smeltepunkt 138 - 140°C (af acetone), rac.N-(3,4-dimethoxyphenylethyl)-N, fi-dimethyl-3[2-(3,4-dimethoxy-phenyl)-m-dithian-2-yl]propylamin-oxalat (1:1) med smeltepunkt 138 - 139°C (af acetone/ethylacetat), ud fra 2-(3,4-dimethoxy-phenyl)-m-dithian og N-(3-chlor-2-methylpropyl)-N-methyl-3,4-dimethoxy-phenylethylamin og N- [4- (3,4-dimethoxyphenyl)butyl]-N-methyl-3[2-(3,4-dimethoxyphenyl)-m-dithian-2-y1]propylamin.N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (3,4,5-trimethoxyphenyl) - m -dithian-2-yl] propylamine hydrochloride, m.p. 147-150 ° C ( of acetone), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (p-methoxyphenyl) -m-diethian-2-yl] propylamine hydrochloride, m.p. 160 - 161 ° C (of acetone), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (o-methoxyphenyl) -m-diethian-2-yl] propylamine hydrochloride, m.p. 151 - 152 ° C (of acetone ), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (p-chlorophenyl) -m-di-. thian-2-yl] propylamine hydrochloride, m.p. 137 - 139 ° C (of acetone), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2-phenyl-m-dithian-2-yl] - propylamine hydrochloride, m.p. 170 DEG-172 DEG C. (of acetone), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (3,4-methylenedioxyphenyl) - m -dithian-2-yl] propylamine hydrochloride, mp 139-141 ° C (of acetone), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (p-tolyl) -m-dithian-2-yl] propylamine hydrochloride with m.p. 139-141 ° C (of acetone), N- (3,4-dimethoxyphenylethyl) -N-methyl-m-3 [2- (m-chlorophenyl) -m-dithian-2-yl] propylamine hydrochloride with mp 108 - 110 ° C (of acetone), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (3,5-dimethoxyphenyl) - m -dithian-2-yl] propylamine oxalate ( 1: 1), mp 155 - 156 "C (of acetone), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (p-dimethylaminophenyl) - m -dithian-2-yl] propylamine hydrochloride, m.p. 183 - 184 ° C (of acetone), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (2,4,5-trimethoxyphenyl) - md ithian-2-yl] propylamine hydrochloride, mp 156 - 158 ° C (of acetone), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (p-fluorophenyl) -m-diethian-2 -yl] propylamine hydrochloride, m.p. 138-139 ° C (of acetone), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (4-biphenylyl) -m-diethian-2-yl] propylamine oxalate (1: 1), m.p. 167 - 169 ° C (of acetone), N- (p-chlorophenylethyl) -N-methyl-3 [2-phenyl-m-dithian-2-yl] -propylamine hydrochloride, m.p. 145 - 147 "C (of acetone), from 2-phenyl-m-dithian and N- (3-chloropropyl) -N-methyl-4-chloro-phenylethylamine, N-methyl-N-phenylethyl 3 [2-phenyl-m-dithian-2-yl] propylamine hydrochloride, m.p. 136-137 ° C (of acetone) from 2-phenyl-m-dithian ~ and N- (3-chlorophenyl) -N- methylphenylethylamine (b.p. 78 - 80eC / 0.001 mm Hg), N- (3,4-dimethoxyphenylethyl) -N-methyl-2 [2-phenyl-m-dithian-2-yl] ethylamine hydrochloride, m.p. 172 - 174 " C (of acetone) from 2-phenyl-m-dithian and N- (2-chloroethyl) -3,4-dimethoxy-N - methylphenyl thylamine, N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (2-thienyl) -m-dithian-2-yl] propylamine hydrochloride, mp 138-140 ° C (of acetone), rac.N- (3,4-dimethoxyphenylethyl) -N, 5-dimethyl-3 [2- (3,4-dimethoxy-phenyl) -m-dithian-2-yl] propylamine oxalate (1: 1), m.p. 138 - 139 ° C (of acetone / ethyl acetate), from 2- (3,4-dimethoxy-phenyl) -m-dithian and N- (3-chloro-2-methylpropyl) -N-methyl-3,4- dimethoxy-phenylethylamine and N- [4- (3,4-dimethoxyphenyl) butyl] -N-methyl-3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propylamine.

Analyse:Analysis:

Beregnet: C 64,70 H 7,95 N 2,69 Pundet: C 64,42 H 8,11 N 2,58Calculated: C 64.70 H 7.95 N 2.69 Pound: C 64.42 H 8.11 N 2.58

Eksempel 2.Example 2.

35,2 g 2-(3,4-dimethoxyphenyl)-m-dithian-1,1,3,3-tetraOXid (fremstillet ifølge fremstilling 2) suspenderes i 180 ml absolut dioxan, og der tilsættes 2,53 g natrium. Blandingen koges i 20 timer under argon, hvorved natriummet fuldstændigt går i opløsning. Derefter tilsættes 27,2 g N-(3-chlorpropyl)-N-methyl-3,4-dimethoxy-phenylethylamin (fremstillet ifølge eksempel 1) ved stuetemperatur, og den uklare opløsning omrøres i 1 time ved stuetemperatur og koges i 3 timer under tilbagesvaling. Blandingen hældes på is-vand og ekstraheres tre gange med ethylacetat. Ethylacetatekstrakterne forenes og ekstraheres tre gange med IN saltsyre. De sure ekstrakter gøres alkaliske og ekstraheres tre gange med chloroform. Chloroformekstrakterne forenes, 148323 26 vaskes med vand, tørres med magnesiumsulfat og inddampes. Den krystallinske remanens omkrystalliseres af methanol, hvorved fås krystaller med smeltepunkt 143 - 145°C.35.2 g of 2- (3,4-dimethoxyphenyl) -m-dithian-1,1,3,3-tetraOXide (prepared according to Preparation 2) are suspended in 180 ml of absolute dioxane and 2.53 g of sodium is added. The mixture is boiled for 20 hours under argon, thereby completely dissolving the sodium. Then 27.2 g of N- (3-chloropropyl) -N-methyl-3,4-dimethoxy-phenylethylamine (prepared according to Example 1) is added at room temperature and the turbid solution is stirred for 1 hour at room temperature and boiled for 3 hours. reflux. The mixture is poured onto ice-water and extracted three times with ethyl acetate. The ethyl acetate extracts are combined and extracted three times with 1 N hydrochloric acid. The acidic extracts are made alkaline and extracted three times with chloroform. The chloroform extracts are combined, washed with water, dried with magnesium sulfate and evaporated. The crystalline residue is recrystallized from methanol to give crystals of mp 143-145 ° C.

Til fremstilling af hydrochloridet opløses basen i acetone, og i et isbad tilsættes 20 ml dioxanisk hydrogenchlorid. Det krystallinske salt frafiltreres og omkrystalliseres af acetonitril-acetone (1:3).To prepare the hydrochloride, the base is dissolved in acetone and in an ice bath 20 ml of dioxanic hydrogen chloride is added. The crystalline salt is filtered off and recrystallized from acetonitrile-acetone (1: 3).

Det resulterende N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(3,4-dimethoxyphenyl)-m-dithian-2-yl]propylamin-1,1,3,3-tetraoxid-hydrochlorid tørres natten over i højvakuum ved 120'C. Der fås 38,9 g af et produkt med smeltepunkt 167 - 169eC.The resulting N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propylamine-1,1,3,3-tetraoxide hydrochloride is dried overnight in high vacuum at 120 ° C. 38.9 g of a product of melting point 167 - 169 ° C is obtained.

.. Analyse:.. Analysis:

Beregnet: C 52,74 H 6,47 N 2,36 Cl 5,99 S 10,83Calculated: C 52.74 H 6.47 N 2.36 Cl 5.99 S 10.83

Fundet: C 52,58 H 6,58 N 2,16 Cl 6,19 S 10,53.Found: C 52.58 H 6.58 N 2.16 Cl 6.19 S 10.53.

De følgende forbindelser kan fremstilles analogt med den ovenfor beskrevne fremgangsmåde: N-(3,4-dimethoxyphenylethyl)-N-methyl-3 [2- (2-naphthyl)-m-dithian-2-yl]--propylamin-l,l,3,3-tetraoxidoxalat (1:1) med smeltepunkt 190 - 191°C (af acetone/methanol), N- (3,4-dimethoxyphenylethyl) -N-methyl- 3 [2- (3,4,5-trimethoxyphenyl)-m--dithian-2-yl]propylamin-l,l,3,3-tetraoxidoxalat (1:1) med smeltepunkt 146 - 148°C (af acetone/ethylacetat), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(m-bromphenyl)-m-dithian-2--yl]-propylamin-1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 158 -160°C (af methanolisk HC1 og ethylacetat), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(m-nitrophenyl)-m-dithian-2--yl]-propylamin-1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 212 -214°C (af acetone), N- (3,4-dimethoxyphenyl) - N-methyl-3 [2- (p-fluorphenyl) -m-dithian-2-pro-pylamin-1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 234 - 236°C (af methanol), N- (3,4-dimethoxyphenylethyl) -N-methyl- 3 [2-phenyl-m-dithian-2-yl]propylamin-1, 1,3,3-tetraoxid-hydrochlorid med smeltepunkt 149eC (sønderdeling) (af methanol), 148323 27 N- (3,4-dimethoxyphenylethyl) - N-ethyl-3 [2- (3,4-dimethoxyphenyl) -m-di-thian-2-yl]propylamin-l,1,3,3-tetraoxidoxalat (1:1) med smeltepunkt 177 - 179°C (af methanol og acetone), ud fra 2-(3,4-dimethoxyphenyl) --m-dithian-1,1,3,3-tetraoxid og N- (3-chlorpropyl) - N-ethyl-3,4-dimethoxy--phenylethylamin, N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(4-isopropylphenyl)-m-di- thian-2-yl]propylamin-1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 225 - 227°C (af dioxanisk HCl/ethylacetat), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(3-trifluormethylphenyl)--m-dithian-2-yl]propylamin-1,1,3,3-tetraoxidoxalat med smeltepunkt 128 - 130°C (af acetone), N-(3,4-dimethoxyphenyl)-N-methyl-3[2-(3,4-dimethoxyphenyl)-m-di-thian-2-yl]propylamin-1,1,3,3-tetraoxid med smeltepunkt 140 - 150°C (af ether), N-[4-(3,4-dimethoxyphenyl)butyl]-3[2-(3,4-dimethoxyphenyl)-m-di- , thian-2-yl]propylamin-1,1,3,3-tetraoxid,The following compounds can be prepared analogously to the procedure described above: N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (2-naphthyl) -m-dithian-2-yl] propylamine-1, 1,3,3-tetraoxide oxalate (1: 1) mp 190 - 191 ° C (of acetone / methanol), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (3,4,5) -trimethoxyphenyl) -m-dithian-2-yl] propylamine-1,1,3,3-tetraoxide oxalate (1: 1), m.p. 146-148 ° C (of acetone / ethyl acetate), N- (3.4 dimethoxyphenylethyl) -N-methyl-3 [2- (m-bromophenyl) -m-dithian-2-yl] -propylamine-1,1,3,3-tetraoxide hydrochloride, mp 158-160 ° C (of methanolic HCl and ethyl acetate), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (m-nitrophenyl) -m-dithian-2-yl] propylamine-1,1,3,3-tetraoxide hydrochloride, mp 212 -214 ° C (of acetone), N- (3,4-dimethoxyphenyl) - N-methyl-3 [2- (p-fluorophenyl) -m-dithian-2-propylamine-1, 1,3,3-tetraoxide hydrochloride, mp 234 - 236 ° C (of methanol), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2-phenyl-m-dithian-2-y l] propylamine-1,3,3-tetraoxide hydrochloride, mp 149 DEG C. (decomposition) (of methanol), N- (3,4-dimethoxyphenylethyl) - N-ethyl-3 [2- (3.4 -dimethoxyphenyl) -m-di-thian-2-yl] propylamine-1,3,3-tetraoxide oxalate (1: 1), m.p. 177 - 179 ° C (of methanol and acetone), from 2- (3 4-Dimethoxyphenyl) -m-dithian-1,1,3,3-tetraoxide and N- (3-chloropropyl) - N-ethyl-3,4-dimethoxy-phenylethylamine, N- (3,4-dimethoxyphenylethyl) ) -N-methyl-3 [2- (4-isopropylphenyl) -m-diethian-2-yl] propylamine-1,1,3,3-tetraoxide hydrochloride, mp 225-2227 ° C (of dioxanic HCl (ethyl acetate), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (3-trifluoromethylphenyl) - m -dithian-2-yl] propylamine-1,1,3,3-tetraoxide oxalate, m.p. 128-130 ° C (of acetone), N- (3,4-dimethoxyphenyl) -N-methyl-3 [2- (3,4-dimethoxyphenyl) -m-di-thian-2-yl] propylamine-1, 1,3,3-tetraoxide, m.p. 140-150 ° C (of ether), N- [4- (3,4-dimethoxyphenyl) butyl] -3 [2- (3,4-dimethoxyphenyl) -m-di , thian-2-yl] propylamine-1,1,3,3-tetrao dioxide,

Analyse:Analysis:

Beregnet : C 57,61 H 7,08 N 2,40 Fundet: C 57,78 H 7,10 N 2,39 N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(3,4-xylyl)-m-dithian-2-yl]-propylamin-1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 176 -178°C (af acetonitril), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(3-butoxy-4-methoxyphenyl)--m-dithian-2-yl]propylamin-1,1,3,3-tetraoxid med smeltepunkt 84 - 85°C (af methanol/isopropylether).Calculated: C 57.61 H 7.08 N 2.40 Found: C 57.78 H 7.10 N 2.39 N- (3,4-Dimethoxyphenylethyl) -N-methyl-3 [2- (3.4 -xylyl) -m-dithian-2-yl] -propylamine-1,1,3,3-tetraoxide hydrochloride, m.p. 176 -178 ° C (of acetonitrile), N- (3,4-dimethoxyphenylethyl) -N- methyl 3 [2- (3-butoxy-4-methoxyphenyl) - m -dithian-2-yl] propylamine-1,1,3,3-tetraoxide, mp 84-85 ° C (of methanol / isopropyl ether).

N-(3-[21-(3,4-dimethoxyphenyl)-m-dithian-2'-yl]propyl)-N-methyl--1,4-benzodioxan-6-ethylamin-l ^1^3^31 -tetraoxid-hydrochlorid med smeltepunkt 208 - 210eC (af acetonitril), N-[4-(3,4-dimethoxyphenyl)butyl]-N-methyl-3[2-(p-isopropylphenyl)-m--dithian-2-yl]propylamin-1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 148 - 150°C (af ethylacetat/dloxanisk HCl), rac.-N-[3-(3,4-dimethoxyphenyl)-1-methylpropyl]-N-methyl-3[2-(3,4--dimethoxyphenyl)-m-dithian-2-yl]propylamin-1,1,3,3-tetraoxid med smeltepunkt 115 - 117eC, N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(4-ethoxy-3-methoxyphenyl)--m-dithian-2-yl]propylamin-1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 190 - 192°C (af acetonitril), 148323 28 m- [2'-(3-(3,4-dimethoxyphenylethyl)methylamino]propyl)-m-dithian-,-2,-yl]benzonitril-l',1',3',3'-tetraoxid-hydrochlorid med smeltepunkt 160“C (sønderdeling), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(1,4-benzodioxan-6-yl)--m-dithian-2-y1]propylamin-1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 201 - 204°C, N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(4-methoxy-m-tolyl)-N--methyl-m-dithian-2-yl]propylamin-1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 146°C (sønderdeling) (af acetone), m-(2'-[3-([4- (3,4-dimethoxypheny1)butyl]methylamino) propyl] -m-di-thian-2*-yl)benzonitril-1',1',3',3'-tetraoxid-hydrochlorid med smeltepunkt 120 - 122“C (af vand) og N-methyl-N-(p-methylphenylethyl)-3[2-(3,4-dimethoxyphenyl)-m-di-thian-2-yl]propylamin-1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 169 - 171°C (af acetone og ethylacetat).N- (3- [21- (3,4-dimethoxyphenyl) -m-dithian-2'-yl] propyl) -N-methyl-1,4-benzodioxane-6-ethylamine-11.3 -tetraoxide hydrochloride, m.p. 208 - 210 ° C (of acetonitrile), N- [4- (3,4-dimethoxyphenyl) butyl] -N-methyl-3 [2- (p-isopropylphenyl) -m-dithian-2- yl] propylamine-1,1,3,3-tetraoxide hydrochloride, mp 148-150 ° C (of ethyl acetate / dloxanic HCl), rac.-N- [3- (3,4-dimethoxyphenyl) -1-methylpropyl] -N-methyl-3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propylamine-1,1,3,3-tetraoxide, m.p. 115 - 117 ° C, N- (3.4 dimethoxyphenylethyl) -N-methyl-3 [2- (4-ethoxy-3-methoxyphenyl) - m -dithian-2-yl] propylamine-1,1,3,3-tetraoxide hydrochloride, m.p. 190 - 192 ° C (of acetonitrile), m - [2 '- (3- (3,4-dimethoxyphenylethyl) methylamino] propyl) -m-dithian -, - 2, -yl] benzonitrile-1', 1 ', 3', 3'-tetraoxide hydrochloride, m.p. 160 ° C (decomposition), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (1,4-benzodioxan-6-yl) - m -dithian 2-yl] propylamine-1,1,3,3-tetraoxide hydrochloride, m.p. 204 ° C, N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (4-methoxy-m-tolyl) -N - methyl-m-dithian-2-yl] propylamine-1.1 , 3,3-tetraoxide hydrochloride, m.p. 146 DEG C. (decomposition) (of acetone), m- (2 '- [3 - ([4- (3,4-dimethoxyphenyl) butyl] methylamino) propyl] -m- di-thian-2 * -yl) benzonitrile-1 ', 1', 3 ', 3'-tetraoxide hydrochloride, mp 120 - 122 ° C (water) and N-methyl-N- (p-methylphenylethyl) - 3 [2- (3,4-Dimethoxyphenyl) -m-di-thian-2-yl] propylamine-1,1,3,3-tetraoxide hydrochloride, mp 169-171 ° C (of acetone and ethyl acetate).

Eksempel 3.Example 3

6,08 g 2-(3,4-methylendioxyphenyl)-m-dithian-1,1,3,3-tetraoxid (fremstillet ifølge fremstilling 2) omrøres under argon med 25 ml absolut dimethylformamid, og der tilsættes 0,8 g af en 55%'s natrium-hydridsuspension. Blandingen lades reagere i 0,5 time ved stuetemperatur og i 1 time ved 40 °C. Efter afkøling til stuetemperatur tilsættes 4,8 g N-(3-chlorpropyl)-N-methyl-3,4-dimethoxy-phenylethyl-amin (fremstillet ifølge eksempel 1), og blandingen opvarmes i 16 timer ved 100°C. Den afkølede blanding hældes derefter på is og ekstraheres tre gange med ethylacetat. De organiske ekstrakter vaskes med vand, tørres med magnesiumsulfat og inddampes i vakuum. Den resulterende olie opløses i acetone, og der tilsættes 5 ml af en 6N dioxanisk hydrogenchloridopløsning. Det frafiltrerede bundfald omkrystalliseres af acetone. Der fås 7,5 g N-(3,4-dimethoxypheny1-ethyl) -N-methyl-3 [2- (3,4-methylendioxyphenyl)-m-dithian-2-yl]propylamin--1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 247 - 248°C.6.08 g of 2- (3,4-methylenedioxyphenyl) -m-dithian-1,1,3,3-tetraoxide (prepared according to Preparation 2) are stirred under argon with 25 ml of absolute dimethylformamide and 0.8 g of and 55% sodium hydride suspension. The mixture is allowed to react for 0.5 hour at room temperature and for 1 hour at 40 ° C. After cooling to room temperature, 4.8 g of N- (3-chloropropyl) -N-methyl-3,4-dimethoxy-phenylethyl-amine (prepared according to Example 1) is added and the mixture is heated at 100 ° C for 16 hours. The cooled mixture is then poured onto ice and extracted three times with ethyl acetate. The organic extracts are washed with water, dried with magnesium sulfate and evaporated in vacuo. The resulting oil is dissolved in acetone and 5 ml of a 6N dioxanic hydrogen chloride solution is added. The filtered precipitate is recrystallized from acetone. 7.5 g of N- (3,4-dimethoxyphenyl-ethyl) -N-methyl-3 [2- (3,4-methylenedioxyphenyl) -m-dithian-2-yl] propylamine - 1.13 3-tetraoxide hydrochloride, mp 247 - 248 ° C.

Analyse:Analysis:

Beregnet: C 52,12 H 5,95 N 2,43 Fundet: C 51,91 H 5,86 N 2,23.Calculated: C 52.12 H 5.95 N 2.43 Found: C 51.91 H 5.86 N 2.23.

29 14832329 148323

De følgende forbindelser kan fremstilles analogt med den ovenfor beskrevne fremgangsmåde: N- (3,4-dimethoxyphenylethyl)-N-methyl-3[2-p-tolyl~m-dithian-2-ylJ propyl-amin-l,l,3,3-tetraoxid-hydrochlorid med smeltepunkt 203 - 207eC (af acetonitril/acetone), N-(3,4-dimethoxyphenylethyl)-N-methyl~3[2-(4-(benzyloxy)-3-methoxyphe-nyl)-m-dithian-2-yl]propylamin-1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 220 - 221“C (af ethanol), N- (3,4-dimethoxyphenylethyl) -N-methyl- 3 [2- (21 -thienyl) -m-dithian-2-yl·]--propylamin~l,l,3,3-tetraoxid-hydrochlorid med smeltepunkt 179 -182°C (af acetone), N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(3,4-dichlorphenyl)-m-di-thian-2-yl]propylamin-l,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 175 - 177eC (af methanol) og N-(3/4-dimethoxyphenylethyl)-N-methyl-3[2-(3,4-dimethoxyphenyl)-m--dithian-2-yl]ethylamin-l,l,3,3-tetraoxidoxalat (1:1) med smeltepunkt 202 - 204°C (af acetone).The following compounds may be prepared by analogy to the procedure described above: N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2-p-tolyl-m-dithian-2-yl] propylamine-1,1,3 , 3-tetraoxide hydrochloride, mp 203-207 ° C (of acetonitrile / acetone), N- (3,4-dimethoxyphenylethyl) -N-methyl ~ 3 [2- (4- (benzyloxy) -3-methoxyphenyl) - m-dithian-2-yl] propylamine-1,1,3,3-tetraoxide hydrochloride, m.p. 220-221 ° C (of ethanol), N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2 - (21-Thienyl) -m-dithian-2-yl ·] - propylamine -1,1,3,3-tetraoxide hydrochloride, m.p. 179 -182 ° C (of acetone), N- (3.4 dimethoxyphenylethyl) -N-methyl-3 [2- (3,4-dichlorophenyl) -m-di-thian-2-yl] propylamine-1,3,3-tetraoxide hydrochloride, m.p. 175 DEG-177 DEG C. (of methanol ) and N- (3/4-dimethoxyphenylethyl) -N-methyl-3 [2- (3,4-dimethoxyphenyl) -midithian-2-yl] ethylamine-1,1,3,3-tetraoxide oxalate (1 : 1), mp 202 - 204 ° C (of acetone).

Eksempel 4.Example 4

10 g 3 ’ , 4'-dimethoxy-4-(methylveratrylamino)butyrophenon-hydrochlo-rid opløses i 50 ml chloroform, og der tilsættes 3,25 g 1,3-propan-dithiol. Til blandingen ledes ved stuetemperatur hydrogenchlorid.10 g of 3 ', 4'-dimethoxy-4- (methylveratrylamino) butyrophenone hydrochloride are dissolved in 50 ml of chloroform and 3.25 g of 1,3-propanedithiol is added. Hydrochloride is added to the mixture at room temperature.

Efter 24 timers henstand hældes blandingen på vand, gøres basisk med en 3N natriumhydroxidopløsning og ekstraheres med ether. Efter tørring og inddampning af opløsningsmidlet opløses den olieagtige remanens i acetone, og der tilsættes den ækvivalente mængde vandfri oxalsyre. Det krystallinske bundfald omkrystalliseres af acetone. Der fås N-methyl-N-veratryl-3[2-(3,4-dimethoxyphenyl)-m-dithian-2-yl]-propylaminoxalat (1:1) med smeltepunkt 133 - 136°C.After standing for 24 hours, the mixture is poured onto water, basified with a 3N sodium hydroxide solution and extracted with ether. After drying and evaporating the solvent, the oily residue is dissolved in acetone and the equivalent amount of anhydrous oxalic acid is added. The crystalline precipitate is recrystallized from acetone. N-methyl-N-veratryl-3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propylamine oxalate (1: 1) is obtained, mp 133-136 ° C.

Analyse:Analysis:

Beregnet: C 57,12 H 6,57 N 2,47 Fundet: C 56,88 H 6,64 N 2,46.Calculated: C 57.12 H 6.57 N 2.47 Found: C 56.88 H 6.64 N 2.46.

Det som udgangsmateriale anvendte 3’,4'-dimethoxy-4-(methylveratrylamino) butyrophenon kan fremstilles på følgende måde: 148323 30 I en 1 liters rundkolbe anbringes 500 g polyphosphorsyre og 69 g veratro1. Der tilsættes i én portion 61 g 4-chlorsmøresyre, hvorved temperaturen stiger til 55°C. Efter 1 times omrøring hældes hele blandingen på is. Derefter ekstraheres blandingen med en blanding af ether og methylenchlorid (3:1). De organiske ekstrakter vaskes med vand og derefter med en mættet natriumhydrogencarbonatopløsning, ekstraheres derefter med vand, tørres med magnesiumsulfat og inddampes i vakuum.The 3 ', 4'-dimethoxy-4- (methylveratrylamino) butyrophenone used as the starting material can be prepared as follows: 500 g of polyphosphoric acid and 69 g of veratrol are placed in a 1 liter round bottom flask. 61 g of 4-chlorobutyric acid is added in one portion, raising the temperature to 55 ° C. After stirring for 1 hour, the whole mixture is poured onto ice. Then, the mixture is extracted with a mixture of ether and methylene chloride (3: 1). The organic extracts are washed with water and then with a saturated sodium bicarbonate solution, then extracted with water, dried with magnesium sulfate and evaporated in vacuo.

Den resulterende krystalgrød omkrystalliseres af ether. Der fås 62,9 g 3,4-dimethoxy-Y-chlorbutyrophenon med smeltepunkt 91 - 92°C.The resulting crystal porridge is recrystallized from ether. 62.9 g of 3,4-dimethoxy-γ-chlorobutyrophenone are obtained, mp 91-92 ° C.

Til 12 g 3,4-dimethoxy-Y-chlorbutyrophenon sættes 40 ml N-ethyl-N,N--diisopropylamin og 9 g N-methylhomoveratrylamin, og der omrøres i 6 timer ved 120°C. Efter inddampning af opløsningsmidlet i vakuum behandles den viskose masse med ether og natriumhydroxidopløsning.To 12 g of 3,4-dimethoxy-Y-chlorobutyrophenone are added 40 ml of N-ethyl-N, N-diisopropylamine and 9 g of N-methylhomoveratrylamine and stirred at 120 ° C for 6 hours. After evaporation of the solvent in vacuo, the viscous mass is treated with ether and sodium hydroxide solution.

De organiske ekstrakter vaskes med vand og ekstraheres med IN saltsyre. De sure ekstrakter gøres derefter alkaliske og ekstraheres med ether. Etherekstrakterne forenes, tørres med natriumsulfat og inddampes. Det resulterende 3',4'-dimethoxy-4-(methylveratrylamino)butyro-phenon, som ifølge tyndtlagschromatografi er næsten rent, kan anvendes uden yderligere rensning.The organic extracts are washed with water and extracted with 1N hydrochloric acid. The acidic extracts are then made alkaline and extracted with ether. The ether extracts are combined, dried with sodium sulfate and evaporated. The resulting 3 ', 4'-dimethoxy-4- (methylveratrylamino) butyro-phenone, which, by thin layer chromatography, is almost pure, can be used without further purification.

De følgende forbindelser kan fremstilles analogt med den ovenfor beskrevne fremgangsmåde: N-(3,4-dimethoxyphenylethy1)- N-methyl-3 [ 2-(3,4-dimethoxyphenyl)-m--dithian-2-yl]butylaminoxalat (1:1) med smeltepunkt 134 - 136"C (af acetone), ud fra 1,3-propandithiol og 5-[(3,4-dimethoxyphenylethyl)--methylamino]-3',4'-dimethoxyvalerophenon (hydrochloridet har smeltepunkt 165 - 166°C) , som fås ud fra 3,4-dimethoxy-<5 -chlorvalerophenon og N-methylhomoveratrylamin, N- (3,4-dime thoxypheny lethyl) -N-methyl-3 [2- (3,4-dimethoxyphenyl) -m-di-thian-2-yl]pentylaminoxalat (1:1) med smeltepunkt 109 - lll'C (af acetone) ud fra 1,3-propandithiol og 6-[(3,4-dimethoxyphenylethyl)-me-thylamino]-3',4'-dimethoxyhexanophenon (hydrochloridets smeltepunkt 128 - 129eC), som fås ud fra 6-chlor-3',4'-dimethoxyhexanophenon og N-methylhomoveratrylamin, N-[3-(3,4-dimethoxyphenyl)propyl]-N-methyl-3[2-(3,4-dimethoxyphenyl)--m-dithian-2-yl]propylamin-oxalat (1:1) med smeltepunkt 116 - 118“C (af acetone) ud fra 1,3-propandithiol og 3',4'-dimethoxy-4-(T3,4-di- 148323 31 methoxyphenyl)propyl]methylamino)butyrophenon, som fås ud fra 3.4- dimethoxy-y-chlorbutyrophenon og 3-(3,4-dimethoxyphenyl)-N--methylpropylamin, N-methyl-N-(a-methylphenylethyl)-3[2-(3,4-dimethoxyphenyl)-m-dithian--2-yl]propylamin-oxalat (1:1) med smeltepunkt 131 - 132®C (af acetone/ ethylacetat), ud fra 1,3-propandithiol og 4-[(3,4-dimethoxy-a-methyl-phenylethy1)methylamino]-3',4'-dimethoxybutyrophenon, som fås ud fra 3.4- dimethoxy-Y-chlorbutyrophenon og N,a-dimethyl-p-phenylethylamin (kogepunkt = 130 - 140°/20 mm Hg), og N- (3,4-dimethoxyphenyl ethyl) -N-methy1-3 [2- (3,4-dimethoxyphenyl) -1,3--dithiolan-2-yl]propylaminoxalat (1:1) med smeltepunkt 150 - 152eC (af acetone), ud fra 4-[(3,4-dimethoxyphenylethyl)methylamino]-3'^'-dime thoxybuty rophenon og 1,2-ethandithiol.The following compounds can be prepared analogously to the procedure described above: N- (3,4-dimethoxyphenylethyl) - N-methyl-3 [2- (3,4-dimethoxyphenyl) m -dithian-2-yl] butylamine oxalate (1 : 1) with melting point 134 - 136 "C (of acetone), from 1,3-propanedithiol and 5 - [(3,4-dimethoxyphenylethyl) methylamino] -3 ', 4'-dimethoxyvalerophenone (the hydrochloride has melting point 165 - 166 ° C) obtained from 3,4-dimethoxy- <5 -chlorovalerophenone and N-methylhomoveratrylamine, N- (3,4-dime thoxyphenylethyl) -N-methyl-3 [2- (3,4-dimethylamino) dimethoxyphenyl) -m-di-thian-2-yl] pentylamine oxalate (1: 1), m.p. 109-111 ° C (of acetone) from 1,3-propanedithiol and 6 - [(3,4-dimethoxyphenylethyl) -me -thylamino] -3 ', 4'-dimethoxyhexanophenone (m.p. 128 - 129eC) obtained from 6-chloro-3', 4'-dimethoxyhexanophenone and N-methylhomoveratrylamine, N- [3- (3,4-dimethoxyphenyl ) propyl] -N-methyl-3 [2- (3,4-dimethoxyphenyl) - m -dithian-2-yl] propylamine oxalate (1: 1) m.p. 116-118 ° C (of acetone) from 1,3-P ropanedithiol and 3 ', 4'-dimethoxy-4- (T3,4-di-methoxyphenyl) propyl] methylamino) butyrophenone obtained from 3,4-dimethoxy-γ-chlorobutyrophenone and 3- (3,4-dimethoxyphenyl) -N - methylpropylamine, N-methyl-N- (α-methylphenylethyl) -3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propylamine oxalate (1: 1), m.p. - 132 ° C (of acetone / ethyl acetate), from 1,3-propanedithiol and 4 - [(3,4-dimethoxy-α-methyl-phenylethyl) methylamino] -3 ', 4'-dimethoxybutyrophenone, obtained from 3,4-dimethoxy-γ-chlorobutyrophenone and N, α-dimethyl-p-phenylethylamine (boiling point = 130-140 ° / 20 mm Hg), and N- (3,4-dimethoxyphenyl ethyl) -N-methyl1-3 [2- (3,4-dimethoxyphenyl) -1,3-dithiolan-2-yl] propylamine oxalate (1: 1) m.p. 150 DEG-152 DEG C. (of acetone), starting from 4 - [(3,4-dimethoxyphenylethyl) methylamino] - 3 '-' - dime thoxybuty rophenone and 1,2-ethanedithiol.

Eksempel 5.Example 5

Til 10,4 g 2-(3-chlorpropyl)-2-(3,4-dimethoxyphenyl)-m-dithian--1,1,3,3-tetraoxid sættes 5,11 g N-methylhomoveratrylamin, 30 ml N-ethyl-N,N-diisopropylamin og 70 ml dimethylformamid. Opløsningen opvarmes ved 120"C i 6 timer. Efter inddampning behandles remanensen på analog måde som beskrevet i eksempel 3. Der fås N-(3,4-dimethoxy-ph enylethyl)-N-methy1-3[2-(3,4-dimethoxyphenyl)-m-dithian-2-yl]propyl-amin-l,l,3,3-tetraoxid-hydrochlorid med smeltepunkt 167 - 169°C.To 10.4 g of 2- (3-chloropropyl) -2- (3,4-dimethoxyphenyl) -m-dithian-1,1,3,3-tetraoxide are added 5.11 g of N-methylhomoveratrylamine, 30 ml of N- ethyl N, N-diisopropylamine and 70 ml of dimethylformamide. The solution is heated at 120 ° C for 6 hours. After evaporation, the residue is treated in an analogous manner as described in Example 3. N- (3,4-dimethoxy-phenylethyl) -N-methyl-3- [2- (3.4 -dimethoxyphenyl) -m-dithian-2-yl] propylamine-1,1,3,3-tetraoxide hydrochloride, mp 167-169 ° C.

De følgende forbindelser kan fremstilles analogt med den ovenfor beskrevne fremgangsmåde: N-(3,4-dimethoxyphenylethyl)-N-methy1-3[2-phenyl-m-dithian-2-yl]propyl-amin-l,l,3,3-tetraoxid-hydrochlorid med smeltepunkt 149°C (sønderdeling, af methanol), N-(p-chlorphenylethyl) -N-methyl-3[2-pheny1-m-dithian-2-yl]propylamin--1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 246 - 249°C (søndeling, af methanol/methylenchlorid), N-methyl-N-phenylethyl-3[2-phenyl-m-dithian-2-yl]propylamin-1,1,3,3-te-traoxid-hydrochlorid med smeltepunkt 165 - 167.°C (af acetone), N-methy1-N-veratryl-3(2-(3,4-dimethoxyphenyl)-m-dithian-2-yl]propylamin- -1,1,3,3-tetraoxid med smeltepunkt 137 - 139°C (af acetone/ethanol) og 148323 32 N-(3,4-dimethoxyphenylethyl)-3[2-(3,4-dimethoxyphenyl)-m-dithian-2-yl]--propylamin-l,l,3,3-tetraoxid-hydrochlorid med smeltepunkt 130 -132°C (af acetone).The following compounds can be prepared analogously to the procedure described above: N- (3,4-dimethoxyphenylethyl) -N-methyl-3- [2-phenyl-m-dithian-2-yl] propylamine-1,1,3, 3-tetraoxide hydrochloride, m.p. 149 ° C (dec., Of methanol), N- (p-chlorophenylethyl) -N-methyl-3 [2-phenyl-m-dithian-2-yl] propylamine - 1.1, 3,3-tetraoxide hydrochloride, mp 246 - 249 ° C (decomposition, of methanol / methylene chloride), N-methyl-N-phenylethyl-3 [2-phenyl-m-dithian-2-yl] propylamine-1.1 , 3,3-tetraoxide hydrochloride, mp 165 - 167 ° C (of acetone), N-methyl-N-veratryl-3 (2- (3,4-dimethoxyphenyl) -m-dithian-2-yl) ] propylamine -1,1,3,3-tetraoxide, mp 137-139 ° C (of acetone / ethanol) and N- (3,4-dimethoxyphenylethyl) -3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] - propylamine-1,1,3,3-tetraoxide hydrochloride, mp 130-132 ° C (of acetone).

Det ovenfor som udgangsforbindelse anvendte 2-(3-chlorpropyl)-2-(3,4--dimethoxyphenyl)-m-dithian-1,1,3,3-tetraoxid kan fremstilles på følgende måde: 10,9 q 3,4-dimethoxy-Y-chlorbutyrophenon (fremstillet ifølge eksempel 4) opløses i 120 ml chloroform, og ved stuetemperatur tilsættes 5 ml 1,3-propandithiol og 1 ml bortrifluoridetherat. Efter 1 times omrøring ved stuetemperatur vaskes chloroformopløsningen tre gange med vand, tre gange med en IN natriumhydroxidopløsning og tre gange med vand. De organiske faser tørres med magnesiumsulfat og inddampes i vakuum. Den olieagtige remanens opløses straks ved 0 - 5°C i 500 ml chloroform, og der tilsættes 45,7 g fast m-chlorperbenzoesyre på en sådan måde, at reaktionstemperaturen ikke stiger over 5°C. Blandingen lades derefter henstå i 64 timer i køleskab. Den organiske fase vaskes tre gange med en IN natriumhydroxidopløsning og tre gange med vand, tørres med magnesiumsulfat og inddampes i vakuum. Remanensen Omkrystalliseres af methylenchlorid/isopropylether. Der fås 2-(3-chlorpropyl)-2-(3,4-dimethoxyphenyl)-m-dithian-1,1,3,3-tetra-oxid med smeltepunkt 183 - 184°C.The 2- (3-chloropropyl) -2- (3,4-dimethoxyphenyl) -m-dithian-1,1,3,3-tetraoxide used as the starting compound can be prepared as follows: 10.9 q 3.4 -Dimethoxy-Y-chlorobutyrophenone (prepared according to Example 4) is dissolved in 120 ml of chloroform and at room temperature 5 ml of 1,3-propanedithiol and 1 ml of boron trifluoride etherate are added. After stirring at room temperature for 1 hour, the chloroform solution is washed three times with water, three times with 1N sodium hydroxide solution and three times with water. The organic phases are dried over magnesium sulfate and evaporated in vacuo. The oily residue is immediately dissolved at 0 - 5 ° C in 500 ml of chloroform, and 45.7 g of solid m-chloroperbenzoic acid are added in such a way that the reaction temperature does not rise above 5 ° C. The mixture is then left in the refrigerator for 64 hours. The organic phase is washed three times with 1N sodium hydroxide solution and three times with water, dried over magnesium sulfate and evaporated in vacuo. The residue is recrystallized from methylene chloride / isopropyl ether. There is obtained 2- (3-chloropropyl) -2- (3,4-dimethoxyphenyl) -m-dithian-1,1,3,3-tetra-oxide, mp 183 - 184 ° C.

Det ovenfor som udgangsmateriale anvendte 2-(3-chlorpropyl)-2-phenyl--m-dithian-l,l,3,3-tetraoxid kan fremstilles på følgende måde: 19,63 g 2-phenyl-m-dithian opløses i 300 ml tetrahydrofuran. Ved en temperatur på -70°C tildryppes langsomt under tilledning af argon 43,5 ml af en opløsning af butyllithium i hexan. Blandingen omrøres ved -20°C i i alt 1,5 timer. Den resulterende røde opløsning sættes ved -70°C til en opløsning af 15,74 g 1,3-bromchlorpropan i 250 ml absolut tetrahydrofuran. Den resulterende opløsning lades henstå i 1 time ved -20°C og i 1 time ved stuetemperatur. Opløsningsmidlet inddampes i vakuum, og den olieagtige remanens optages i ether. Den etheriske fase vaskes med en IN natriumhydroxidopløsning og med vand, tørres med magnesiumsulfat og inddampes i vakuum. Det resulterende 2-(3-chlorpropyl)-2-phenyl-m-dithian peroxideres ved 0 - 5“C med m-chlorperbenzoesyre i chloroform på analog måde som beskrevet i det foregående afsnit. Der fås efter omkrystallisation af ethyl-acetat 2-(3-chlorpropyl)-2-phenyl-m-dithian-1,1,3,3-tetraoxid med smeltepunkt 182°C.The 2- (3-chloropropyl) -2-phenyl-m-dithian-1,1,3,3-tetraoxide used as the starting material can be prepared as follows: 19.63 g of 2-phenyl-m-dithian are dissolved in 300 ml of tetrahydrofuran. At a temperature of -70 ° C, 43.5 ml of a solution of butyllithium in hexane is slowly added dropwise with argon. The mixture is stirred at -20 ° C for a total of 1.5 hours. The resulting red solution is added at -70 ° C to a solution of 15.74 g of 1,3-bromochloropropane in 250 ml of absolute tetrahydrofuran. The resulting solution is allowed to stand for 1 hour at -20 ° C and for 1 hour at room temperature. The solvent is evaporated in vacuo and the oily residue is taken up in ether. The etheric phase is washed with 1N sodium hydroxide solution and with water, dried over magnesium sulfate and evaporated in vacuo. The resulting 2- (3-chloropropyl) -2-phenyl-m-dithian is peroxidized at 0 - 5 ° C with m-chloroperbenzoic acid in chloroform in an analogous manner as described in the previous section. After recrystallization of ethyl acetate 2- (3-chloropropyl) -2-phenyl-m-dithian-1,1,3,3-tetraoxide is obtained, mp 182 ° C.

148323 33148323 33

Eksempel 6.Example 6

3,76 g 2-(3,4-dimethoxyphenyl)-2-(2,3-epoxypropyl)-m-dithian-1,1,3,3--tetraoxid opvarmes under tilbagesvaling under argon i 18 timer med 50 ml ethanol, 30 ml chloroform og 1,95 g N-methylhomoveratrylamin. Efter afdampning af opløsningsmidlet chromatograferes remanensen på silicagel med chloroform/ethanol (98:2). Den resulterende olie opløses 1 acetone, og der tilsættes en ækvivalent mængde vandfri oxalsyre. Bundfaldet frafiltreres og omkrystalliseres af methanol/acetone. Det resulterende rac.-a-[(3,4-dimethoxyphenylethyl)-methylamino]- -2[2-(3,4-dimethoxyphenyl)-m-dithian-2-y1]ethanol-1,1,3,3-tetraoxid-oxalat (1:1) krystalliserer med 1 mol acetone og smelter ved 162 - 164°C.3.76 g of 2- (3,4-dimethoxyphenyl) -2- (2,3-epoxypropyl) -m-dithian-1,1,3,3-tetraoxide is heated under reflux under argon for 18 hours with 50 ml of ethanol , 30 ml of chloroform and 1.95 g of N-methylhomoveratrylamine. After evaporation of the solvent, the residue is chromatographed on silica gel with chloroform / ethanol (98: 2). The resulting oil is dissolved in acetone and an equivalent amount of anhydrous oxalic acid is added. The precipitate is filtered off and recrystallized from methanol / acetone. The resultant rac-α - [(3,4-dimethoxyphenylethyl) methylamino] -2- [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] ethanol-1,1,3,3- tetraoxide oxalate (1: 1) crystallizes with 1 mole of acetone and melts at 162 - 164 ° C.

Analyse:Analysis:

Beregnet: C 51,73 H 6,30 N 1,95 Fundet: C 51,68 H 6,53 N 2,00.Calculated: C 51.73 H 6.30 N 1.95 Found: C 51.68 H 6.53 N 2.00.

Det som udgangsmateriale anvendte 2-(3,4-dimethoxyphenyl)-2-(2,3-epoxypropyl) -m-dithian-1, 1,3, 3-tetraoxid kan fremstilles på følgende måde: 9,6 g 2-(3,4-dimethoxyphenyl)-m-dithian-1,1,3,3-tetraoxid (fremstillet ifølge fremstilling 2) opløses i 35 ml dimethylformamid, og under omrøring under argon tilsættes ved stuetemperatur 1,2 g natriumhydrid. Suspensionen omrøres i yderligere 0,5 time ved 40®C og afkøles derefter, og der tilsættes 2,8 g epi'chlorhydrin. Derefter opvarmes blandingen i 16 timer ved 100°C. Efter afkøling til stuetemperatur hældes suspensionen på vand, og det olieagtige produkt ekstraheres med chloroform. Efter inddampning af opløsningsmidlet chromatograferes remanensen på silicagel med chloroform/ethanol (98:2).. Det resulterende 2 —(3,4-dimethoxyphenyl)-2-(2,3-epoxypropyl)-m-dithian-1,1,3,3-tetraoxid omkrystalliseres af methylenchlorid/ethanol og har smeltepunkt 175 - 176 °C.The 2- (3,4-dimethoxyphenyl) -2- (2,3-epoxypropyl) -m-dithian-1,1,3,3-tetraoxide used as starting material can be prepared as follows: 9.6 g of 2- ( Dissolve 3,4-dimethoxyphenyl) -m-dithian-1,1,3,3-tetraoxide (prepared according to Preparation 2) in 35 ml of dimethylformamide and, with stirring under argon, add 1.2 g of sodium hydride at room temperature. The suspension is stirred for an additional 0.5 hour at 40 ° C and then cooled, adding 2.8 g of epichlorohydrin. The mixture is then heated for 16 hours at 100 ° C. After cooling to room temperature, the suspension is poured onto water and the oily product is extracted with chloroform. After evaporation of the solvent, the residue is chromatographed on silica gel with chloroform / ethanol (98: 2). The resulting 2- (3,4-dimethoxyphenyl) -2- (2,3-epoxypropyl) -m-dithian-1,1,3 3-Tetraoxide is recrystallized from methylene chloride / ethanol and has a melting point of 175 - 176 ° C.

Eksempel 7.Example 7

3,65 g 2- (3-chlorpropyl)-2-(3,4-dimethoxyphenyl)-m-dithian-1,3-dio-xid, 7,8 g N-methylhomoveratrylamin og 20 ml dimethylsulfoxid opvar 148323 34 mes under argon i 16 timer ved 50°C. Derefter hældes opløsningen i 200 ml vand og gøres stærkt alkalisk. Overskydende N-methylhomovera-trylamin ekstraheres med ether. Den alkaliske opløsning ekstraheres derefter med methylenchlorid. Methylenchloridekstrakterne tørres derefter over magnesiumsulfat. Efter afdampning af opløsningsmidlet optages remanensen i acetone, og der tilsættes dioxanisk hydrochlo-rid, indtil en pH-værdi på ca. 2. Den krystallinske remanens omkrystalliseres af acetone/acetonitril, hvorved fås N-(3,4-dimethoxy-phenylethyl)-N-methyl-3[2-(3,4-dimethoxyphenyl)-m-dithian-2-yl]propyl-amin-l,3-dioxid-hydrochlorid med smeltepunkt 148 - 149“C (diastereomer-blanding).3.65 g of 2- (3-chloropropyl) -2- (3,4-dimethoxyphenyl) -m-dithian-1,3-dioxide, 7.8 g of N-methylhomoveratrylamine and 20 ml of dimethylsulfoxide are stored under reduced pressure. argon for 16 hours at 50 ° C. Then pour the solution into 200 ml of water and make it highly alkaline. Excess N-methylhomoveratrylamine is extracted with ether. The alkaline solution is then extracted with methylene chloride. The methylene chloride extracts are then dried over magnesium sulfate. After evaporation of the solvent, the residue is taken up in acetone and dioxanic hydrochloride is added until a pH of approx. 2. The crystalline residue is recrystallized from acetone / acetonitrile to give N- (3,4-dimethoxy-phenylethyl) -N-methyl-3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propyl -amine-1,3-dioxide hydrochloride, mp 148-149 ° C (diastereomer mixture).

Den som udgangsforbindelse anvendte 2-(3-chlorpropyl)-2-(3,4-dimetho-xyphenyl)-m-dithian-l,3-dioxid kan fremstilles på følgende måde: 76,9 g 2-(3,4-dimethoxyphenyl)-m-dithian (fremstillet ifølge fremstilling 1) opløses i 900 ml absolut tetrahydrofuran, opløsningen afkøles til -70eC, og der tilsættes 128 ml af en butvllithiumopløsning på en sådan måde, at temperaturen ikke stiger over -60°C. Blandingen holdes derefter i 2 timer ved -20°C, hvorved dannes et bundfald.The starting compound used for 2- (3-chloropropyl) -2- (3,4-dimethoxy-xyphenyl) -m-dithian-1,3-dioxide can be prepared as follows: 76.9 g of 2- (3.4- dimethoxyphenyl) -m-dithian (prepared according to Preparation 1) is dissolved in 900 ml of absolute tetrahydrofuran, the solution is cooled to -70 ° C and 128 ml of a butyl lithium solution is added in such a way that the temperature does not rise above -60 ° C. The mixture is then kept for 2 hours at -20 ° C to form a precipitate.

Derefter afkøles blandingen til -70"C, og der tilsættes 47,3 g 1,3-bromchlorpropan i 750 ml absolut tetrahydrofuran. Blandingen holdes derefter i 1 time ved -20“C og i 1 time ved stuetemperatur. Derefter afdampes tetrahydrofuranet, og remanensen optages i ether og ekstraheres. Efter afdampning af opløsningsmidlet fås 2-(3-chlorpropyl)--2-(3,4-dimethoxyphenyl)-m-dithian.The mixture is then cooled to -70 ° C and 47.3 g of 1,3-bromochloropropane are added in 750 ml of absolute tetrahydrofuran. The mixture is then kept for 1 hour at -20 ° C and for 1 hour at room temperature. Then the tetrahydrofuran is evaporated and The residue is taken up in ether and extracted After evaporation of the solvent, 2- (3-chloropropyl) - 2- (3,4-dimethoxyphenyl) -m-dithian is obtained.

55,25 g 2-(3-chlorpropyl)-2-(3,4-dimethoxyphenyl)-m-dithian opløses i 500 ml iseddike. Under omrøring tildryppes ved 5°C i løbet af 2 timer en opløsning af 34 g 30%'s hydrogenperoxid i 300 ml iseddike. Blandingen lades derefter henstå i 60 timer ved stuetemperatur og inddampes derefter i vakuum ved 40 °C. Den resulterende olie chromatograferes på 1,5 kg silicagel med chloroform/ethanol (først 98:2, derefter 95:5). Der fås efter omkrystållisation af acetonitril 2-(3-chlorpropyl)-2--(3,4-dimethoxyphenyl)-m-dithian-l,3-dioxid med smeltepunkt 163 -164“C (diastereomerblanding).Dissolve 55.25 g of 2- (3-chloropropyl) -2- (3,4-dimethoxyphenyl) -m-dithian in 500 ml glacial acetic acid. With stirring, a solution of 34 g of 30% hydrogen peroxide in 300 ml of glacial acetic acid is added dropwise at 5 ° C over 2 hours. The mixture is then allowed to stand for 60 hours at room temperature and then evaporated in vacuo at 40 ° C. The resulting oil is chromatographed on 1.5 kg of silica gel with chloroform / ethanol (first 98: 2, then 95: 5). There is obtained after recrystallization of acetonitrile 2- (3-chloropropyl) -2- (3,4-dimethoxyphenyl) -m-dithian-1,3-dioxide, mp 163 -164 ° C (diastereomer mixture).

Eksempel 8.Example 8.

På analog måde som beskrevet i eksempel 6 fremstilles ud fra 2-(3,4-dime- 148323 35 thoxyphenyl)-2-- (2,3-epoxypropyl)-m-dithian og N-methylhomovera-trylamin rac.-a-[(3,4-dimethoxyphenylethyl)-methylamino]-methyl-2 [2-(3,4-dimethoxyphenyl)-m-dithian-2-yl]ethanol. Det tilsvarende hydrobromid krystalliseres af acetonitril/ethylacetat og smelter ved 97 - 99°C.In an analogous manner as described in Example 6, from 2- (3,4-dimethoxyphenyl) -2- (2,3-epoxypropyl) -m-dithian and N-methylhomoveratrylamine rac. [(3,4-dimethoxyphenylethyl) methylamino] -methyl-2 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] ethanol. The corresponding hydrobromide is crystallized by acetonitrile / ethyl acetate and melts at 97 - 99 ° C.

Det som udgangsmateriale anvendte 2-(3,4-dimethoxyphenyl)-2-(2,3--epoxypropyl)-m-dithian kan på analog måde som beskrevet i eksempel 7 fremstilles ud fra 2-(3,4-dimethoxyphenyl)-m-dithian (fremstillet ifølge fremstilling 1) under anvendelse af epichlorhydrin i stedet for 1,3-bromchlorpropan.The 2- (3,4-dimethoxyphenyl) -2- (2,3-epoxypropyl) -m-dithian used as starting material can be prepared from 2- (3,4-dimethoxyphenyl) by analogy as described in Example 7. m-dithian (prepared according to Preparation 1) using epichlorohydrin instead of 1,3-bromochloropropane.

Eksempel 9.Example 9

3,4 g lithiumaluminiumhydrid opvarmes under tilbagesvaling i 60 ml tetrahydrofuran. Derefter tilsættes dråbevis 14,7 g N-(3,4-dimethyl-phenylethyl)-3[2-(3,4-dimethoxyphenyl)-m-dithian-2-yl]propionamid i 80 ml tetrahydrofuran. Den resulterende suspension opvarmes under tilbagesvaling i 3 timer og afkøles derefter til O'C, og der tilsættes forsigtigt 50 ml af en mættet natriumsulfatopløsning. Blandingen filtreres, og opløsningen fortyndes med vand og ekstraheres med ether.3.4 g of lithium aluminum hydride is heated to reflux in 60 ml of tetrahydrofuran. Then 14.7 g of N- (3,4-dimethyl-phenylethyl) -3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propionamide is added dropwise in 80 ml of tetrahydrofuran. The resulting suspension is heated at reflux for 3 hours and then cooled to 0 ° C and gently added 50 ml of a saturated sodium sulfate solution. The mixture is filtered and the solution is diluted with water and extracted with ether.

De etheriske ekstrakter vaskes med IN natriumhydroxidopløsning og derefter med vand, tørres med magnesiumsulfat og inddampes. Den olie-agtige remanens chromatograferes på silicagel med chloroform/ethanol (95:5). Den resulterende base opløses i acetone, og der tilsættes den ækvivalente mængde vandfri oxalsyre. Det resulterende bundfald omkrystalliseres af methanol/acetone. Det resulterende N-(3,4-dimethoxyphenylethyl) -3 [2-(3,4-dimethoxyphenyl) -m-dithian-2-yl]propylamin--oxalat (1:1) smelter ved 186 - 188“C.The ethereal extracts are washed with 1N sodium hydroxide solution and then with water, dried over magnesium sulfate and evaporated. The oily residue is chromatographed on silica gel with chloroform / ethanol (95: 5). The resulting base is dissolved in acetone and the equivalent amount of anhydrous oxalic acid is added. The resulting precipitate is recrystallized from methanol / acetone. The resulting N- (3,4-dimethoxyphenylethyl) -3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propylamine oxalate (1: 1) melts at 186 - 188 ° C.

Analyse:Analysis:

Beregnet: C 57,12 H 6,57 N 2,67 Fundet: C 56,97 H 6,73 N 2,39.Calculated: C 57.12 H 6.57 N 2.67 Found: C 56.97 H 6.73 N 2.39.

Det som udgangsmateriale anvendte N-(3,4-dimethoxyphenylethyl)-3[2--(3,4-dimethoxyphenyl)-m-dithian-2-yl]propionamid kan fremstilles på følgende måde: 148323 36The N- (3,4-dimethoxyphenylethyl) -3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propionamide used as the starting material can be prepared as follows:

Til 50 g 3-veratroylpropionsyre i 400 ml chloroform og 22,7 g 1,3--propandithiol sættes under omrøring hydrogenchlorid indtil mætning. Efter 3 timers forløb ved stuetemperatur inddampes opløsningen til 50 ml og fortyndes med ether. Opløsningen ekstraheres tre gange med 5%'s natriumcarbonat. De basiske faser forenes og gøres sure med koncentreret saltsyre. Det udfældede produkt ekstraheres med ether/ methylenchlorid (1:3). De organiske ekstrakter tørres og inddampes. Remanensen omkrystalliseres af ethanol, hvorved fås 2-(3,4-dimethoxy-phenyl)-m-dithian-2-propionsyre med smeltepunkt 134 - 135°C.To 50 g of 3-veratroylpropionic acid in 400 ml of chloroform and 22.7 g of 1,3-propanedithiol are added with stirring hydrogen chloride until saturation. After 3 hours at room temperature, the solution is evaporated to 50 ml and diluted with ether. The solution is extracted three times with 5% sodium carbonate. The basic phases are combined and acidified with concentrated hydrochloric acid. The precipitated product is extracted with ether / methylene chloride (1: 3). The organic extracts are dried and evaporated. The residue is recrystallized from ethanol to give 2- (3,4-dimethoxy-phenyl) -m-dithian-2-propionic acid, mp 134-135 ° C.

13,2 g 2-(3,4-dimethoxyphenyl)-m-dithian-2-propionsyre, 4 g triethyl-amin og 180 ml tetrahydrofuran afkøles til 0°C, og der tilsættes dråbevis i løbet af 10 minutter 5,44 g chlormyresyreisobutylester i 80 ml tetrahydrofuran. Derefter' holdes blandingen i 3 timer ved stuetemperatur, og derefter tilsættes ved 0°C 7,25 g homoveratrylamin i 40 ml tetrahydrofuran. Suspensionen lades henstå i 48 timer ved 3°C og inddampes derefter, og der tilsættes vand og ekstraheres med ether/ methylenchlorid (3:1). De etheriske ekstrakter vaskes med vand, na-triumhydrogencarbonat, IN vinsyre og vand. Den organiske fase tørres med magnesiumsulfat og inddampes. Remanensen krystalliseres ved 0°C af methylenchlorid/ether. Der fås N-(3,4-dimethyloxyphenyl-ethyl)-3[2-(3,4-dimethoxyphenyl)-m-dithian-2-yl]propionamid med smeltepunkt 135 - 136°C.13.2 g of 2- (3,4-dimethoxyphenyl) -m-dithian-2-propionic acid, 4 g of triethylamine and 180 ml of tetrahydrofuran are cooled to 0 ° C and 5.44 g are added dropwise over 10 minutes. chloromyric acid oreobutyl ester in 80 ml of tetrahydrofuran. Then, the mixture is kept at room temperature for 3 hours and then 7.25 g of homoveratrylamine in 40 ml of tetrahydrofuran is added at 0 ° C. The suspension is allowed to stand for 48 hours at 3 ° C and then evaporated and water is added and extracted with ether / methylene chloride (3: 1). The ethereal extracts are washed with water, sodium hydrogen carbonate, 1N tartaric acid and water. The organic phase is dried over magnesium sulfate and evaporated. The residue is crystallized at 0 ° C by methylene chloride / ether. N- (3,4-dimethyloxyphenyl-ethyl) -3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propionamide is obtained, mp 135-136 ° C.

På analog måde som beskrevet ovenfor kan N-(3,4-dimethoxyphenyl-e thyl)-3[2-(3,4-dimethoxyphenyl)-N-methy1-m-dithian-2-y1]propylamin-hy-drobromid fremstilles. Smeltepunkt 170 - 172°C (af ethanol).By analogy as described above, N- (3,4-dimethoxyphenyl-ethyl) -3 [2- (3,4-dimethoxyphenyl) -N-methyl-m-dithian-2-yl] propylamine hydrobromide can be prepared . Melting point 170 - 172 ° C (of ethanol).

Eksempel 10.Example 10.

0,5 g 2-['(3-[2"-(3,4-dimethoxyphenyl)-m~dithian-2"-yl]-propyl) --methylamino]-31,4'-dimethoxyacetophenon-1",1",3",3"-tetraoxid opløses i 15 ml ethanol og 30 ml tetrahydrofuran, og der tilsættes 50 mg natriumborhydrid. Efter 16 timers omrøring sættes 15 ml IN saltsyre og derefter 12 ml IN natriumhydroxid til blandingen. Tetra-hydrofuranet afdampes, og remanensen ekstraheres med methylenchlorid.0.5 g of 2 - ['(3- [2 "- (3,4-dimethoxyphenyl) -midithian-2" -yl] -propyl) -methylamino] -31,4'-dimethoxyacetophenone-1 ", Dissolve 1 ", 3", 3 "tetraoxide in 15 ml of ethanol and 30 ml of tetrahydrofuran and add 50 mg of sodium borohydride. After 16 hours of stirring, 15 ml of 1N hydrochloric acid and then 12 ml 1N sodium hydroxide are added to the mixture. The tetrahydrofuran is evaporated and the residue is extracted with methylene chloride.

De organiske ekstrakter vaskes med vand, tørres med magnesiumsulfat 148323 37 og inddampes i vakuum. De resulterende krystaller omkrystalliseres af methanol, hvorved fås 0,3 g a-([(3-[2'-(3,4-dimethoxyphenyl)-m--dithian-2,-yl]propyl)-methylamino]methyl)veratrylalkohol-l' ,1^3^3^ -tetraoxid. Smeltepunkt 132 - 133“C.The organic extracts are washed with water, dried with magnesium sulfate and evaporated in vacuo. The resulting crystals are recrystallized from methanol to give 0.3 g of α - ([(3- [2 '- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propyl) methylamino] methyl) veratryl alcohol -l ', 1 ^ 3 ^ 3 ^ -tetra oxide. Melting point 132 - 133 ° C.

Det som udgangsmateriale anvendte 2-[(3-[2"-(3,4-dimethoxyphenyl)--m-dithian-2"-yl]-propyl)-methylamino]-3',4'-dimethoxyacetophenon--1",1",3",3"-tetraoxid kan fremstilles ved omsætning af 2-(3-chlor-propyl)-2-(3,4-dimethoxyphenyl)-m-dithian-1,1,3,3-tetraoxid og o)-methylamino-3,4-dimethoxyacetophenon. Smeltepunkt 140eC (sønderdeling, af acetone).The starting material used was 2 - [(3- [2 "- (3,4-dimethoxyphenyl) - m -dithian-2" -yl] propyl) methylamino] -3 ', 4'-dimethoxyacetophenone - 1 " , 1 ", 3", 3 "tetraoxide can be prepared by reacting 2- (3-chloro-propyl) -2- (3,4-dimethoxyphenyl) -m-dithian-1,1,3,3-tetraoxide and o) methylamino-3,4-dimethoxyacetophenone. Melting point 140 ° C (decomposition, of acetone).

Eksempel 11.Example 11.

10 g N-(3,4-dimethoxyphenylethyl)-2-(3,4-dimethoxyphenyl)-N-methyl--m-dithian-2-pentylamin (fremstillet ifølge eksempel 4) opløses i 50 ml iseddike og behandles ved stuetemperatur med 20 ml 30%'s hydro-genperoxid. Efter 3 timers forløb opvarmes blandingen i 3 timer til 35°C og derefter i 18 timer til 40°C. Opløsningen hældes derefter på vand, gøres basisk med natriumhydroxid og ekstraheres med methy-lenchlorid. Efter fjernelse af opløsningsmidlet chromatograferes remanensen på silicagel med en blanding af chloroform/methanol/mæt-tet ammoniak (97:3). Det resulterende produkt opløses i acetone, og der tilsættes den ækvivalente mængde oxalsyre. Det resulterende bundfald omkrystalliseres af acetone/methanol. Der fås N-(3,4-dimethoxyphenylethyl ) -N-methyl-5 [2-(3,4-dimethoxyphenyl)-N-methy1-m-di-thian-2-yl]pentylamin-l,l,3,3-tetraoxid-oxalat (1:1) med smeltepunkt 189 -191eC.10 g of N- (3,4-dimethoxyphenylethyl) -2- (3,4-dimethoxyphenyl) -N-methyl-m-dithian-2-pentylamine (prepared according to Example 4) are dissolved in 50 ml of glacial acetic acid and treated at room temperature with 20 ml of 30% hydrogen peroxide. After 3 hours, the mixture is heated to 35 ° C for 3 hours and then to 40 ° C for 18 hours. The solution is then poured into water, basified with sodium hydroxide and extracted with methylene chloride. After removal of the solvent, the residue is chromatographed on silica gel with a mixture of chloroform / methanol / saturated ammonia (97: 3). The resulting product is dissolved in acetone and the equivalent amount of oxalic acid is added. The resulting precipitate is recrystallized from acetone / methanol. N- (3,4-dimethoxyphenylethyl) -N-methyl-5 [2- (3,4-dimethoxyphenyl) -N-methyl-m-di-thian-2-yl] pentylamine-1,1,3 3-tetraoxide oxalate (1: 1), m.p. 189 -191 ° C.

Analyse:Analysis:

Beregnet: C 53,48 H 6,43 N 2,08 Fundet: C 53,37 H 6,50 N 1,87.Calculated: C 53.48 H 6.43 N 2.08 Found: C 53.37 H 6.50 N 1.87.

De følgende forbindelser kan fremstilles analogt med den ovenfor beskrevne fremgangsmåde: 148323 38 N- (3,4-dimethoxyphenylethyl)-N-methy1-4[2-(3,4-dimethoxyphenyl)-m--dithian-2-yl]butylamin-l,l,3,3-tetraoxid-oxalat med smeltepunkt 161 - 163eC (af acetone/methanol), (base: 123 - 126°C (af ethanol)) ud fra N-(3,4-dimethoxyphenylethyl)-N-methy1-4[2-(3,4-dimethoxyphenyl)-N--methyl-m-dithian-2-yl]butylamin (fremstillet ifølge eksempel 4 ) , N-[3-(3,4-dimethoxyphenyl)propyl]-N-methy1-3[2-(3,4-dimethoxyphenyl)--m-dithian-2-yl]propylamin-1,1,3,3-tetraoxid-hydrobromid med smeltepunkt 138 - 140°C (af acetonitril/ethylacetat). ud fra N-[3-(3,4--dimethoxyphenyl)propyl]-N-methy1-3[2-(3,4-dimethoxyphenyl-m-dithian--2-yl]propylamin (fremstillet ifølge eksempel 4), rac.-N-(3,4-dimethoxyphenylethyl)-N, 8-dimethyl-3[2-(3,4-dimethoxyphe-nyl-m-dithian-2-yl]propylamin-1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 183 - 185°C (af acetone/ethylacetat), ud fra rac.-N--(3,4-dimethoxyphenylethyl) -N, 8-dimethyl-3 [2-(3,4-dimethoxyphenyl) --m-dithian-2-yl]propylamin (fremstillet ifølge eksempel lj , og N-methy1-N-(α-methylphenylethyl)-3[2-(3,4-dimethoxyphenyl)-m-dithian--2-yl]propylamin-1,1,3,3-tetraoxid-hydrochlorid med smeltepunkt 185 -187°C (af acetone/ethylacetat), ud fra N-methyl-N-(α-methy1-phenyl-ethyl) -3[2-(3,4-dimethoxyphenyl)-m-dithian-2-yl]propylamin (fremstillet ifølge eksempel 4).The following compounds can be prepared analogously to the procedure described above: N- (3,4-dimethoxyphenylethyl) -N-methyl-4- [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] butylamine -1,1,3,3-tetraoxide oxalate, m.p. 161 - 163 ° C (of acetone / methanol), (base: 123 - 126 ° C (of ethanol)) from N- (3,4-dimethoxyphenylethyl) -N -methyl 1- [2- (3,4-dimethoxyphenyl) -N - methyl-m-dithian-2-yl] butylamine (prepared according to Example 4), N- [3- (3,4-dimethoxyphenyl) propyl] -N-methyl-3- [2- (3,4-dimethoxyphenyl) - m -dithian-2-yl] propylamine-1,1,3,3-tetraoxide hydrobromide, m.p. 138-140 ° C (of acetonitrile / ethyl acetate). from N- [3- (3,4-dimethoxyphenyl) propyl] -N-methyl-3- [2- (3,4-dimethoxyphenyl-m-dithian-2-yl] propylamine (prepared according to Example 4), rac.-N- (3,4-dimethoxyphenylethyl) -N, 8-dimethyl-3 [2- (3,4-dimethoxyphenyl-m-dithian-2-yl] propylamine-1,1,3,3- tetraoxide hydrochloride, mp 183 - 185 ° C (of acetone / ethyl acetate), from rac-N - (3,4-dimethoxyphenylethyl) -N, 8-dimethyl-3 [2- (3,4-dimethoxyphenyl) - m -dithian-2-yl] propylamine (prepared according to Example 1j) and N-methyl-N- (α-methylphenylethyl) -3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl ] propylamine-1,1,3,3-tetraoxide hydrochloride, mp 185 -187 ° C (of acetone / ethyl acetate), from N-methyl-N- (α-methyl-phenyl-ethyl) -3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propylamine (prepared according to Example 4).

Eksempel 12.Example 12.

11,2 g 2-[4-(benzyloxy)-3-methoxyphenyl]-N-(3,4-dimethoxyphenylethyl)--N-methyl-m-dithian-2-propylamin-l,1,3,3-tetraoxid (fremstillet ifølge eksempel 3) opvarmes i 2 minutter på et dampbad med 100 ml 48%'s brombrintesyre. Den vandige opløsning ekstraheres derefter- med ether, inddampes i vakuum og destilleres tre gange azeotropisk med ethanol/ benzen. Remanensen krystalliseres af acetone. Den resulterende krystallinske masse omkrystalliseres tre gange af methanol/åcetonitril, hvorved fås 4-[2'-(3-[(3,4-dimethoxyphenylethyl)methylamino]propyl)--m-dithian^'-yll^-methoxyphenol-l1,1',3',3'-tetraoxid-hydrobromid med smeltepunkt 192°C (sønderdeling).11.2 g of 2- [4- (benzyloxy) -3-methoxyphenyl] -N- (3,4-dimethoxyphenylethyl) - N-methyl-m-dithian-2-propylamine-1,3,3-tetraoxide (prepared according to Example 3) is heated for 2 minutes on a steam bath with 100 ml of 48% hydrochloric acid. The aqueous solution is then extracted with ether, evaporated in vacuo and distilled azeotropically three times with ethanol / benzene. The residue is crystallized by acetone. The resulting crystalline mass is recrystallized three times by methanol / acetonitrile to give 4- [2 '- (3 - [(3,4-dimethoxyphenylethyl) methylamino] propyl) - m -dithian 1 ', 3', 3'-tetraoxide hydrobromide, mp 192 ° C (dec.).

Analyse:Analysis:

Beregnet for c25H35N08S2‘HBr: C 48,23 H 5,83 N 2,25 • Fundet: C 48,12 H 5,93 N 2,07.Calcd for C25H35NO8S2HHbr: C, 48.23;

39 148323 På analog måde fås ud fra N-(2,4-dimethoxyphenylethyl)-N-methyl--3 [2- [3- (benzyloxy) -4-methoxyphenyl]-m-dithian-2-yl]pro]ylamin-l,l,3,3-tetra-oxid 5-[2'-(3-[(3,4-dimethoxyphenylethyl)-methylamino]propyl)' -m-dithian-2 '-yl]-2-methoxyphen ol-l1,1',31,3'-tetraoxid-hydro-bromid med smeltepunkt 201°C (sønderdeling, af acetonitril).Analogously obtained from N- (2,4-dimethoxyphenylethyl) -N-methyl-3 [2- [3- (benzyloxy) -4-methoxyphenyl] -m-dithian-2-yl] pro] ylamine -1,1,3,3-tetra-oxide 5- [2 '- (3 - [(3,4-dimethoxyphenylethyl) methylamino] propyl)' -m-dithian-2'-yl] -2-methoxyphenol -1,1 ', 31,3'-tetraoxide hydrobromide, mp 201 ° C (decomposition, of acetonitrile).

Eksempel 13.Example 13

2 g 5-[2'-(3-[(3,4-dimethoxyphenylethyl)methylamino]propyl)-m-di-thian-2'-yl]-2-methoxyphenol-l',Γ1,3',3'-tetraoxid opløses i absolut pyridin, og der tilsættes et overskud af eddikesyreanhydrid. Efter 16 timers forløb ved stuetemperatur inddampes opløsningsmidlet, og remanensen chromatograferes på silicagel. 5-[2'-(3-[(3,4-dimethoxyphenylethyl) methylamino]propyl)-m-dithian-2'-yl]-2-methoxyphenyl-acetat-1',1',3',3'-tetraoxid i form af en tyk olie.2 g of 5- [2 '- (3 - [(3,4-dimethoxyphenylethyl) methylamino] propyl) -m-di-thian-2'-yl] -2-methoxyphenol-1', ,31,3 ', 3' -tetra oxide is dissolved in absolute pyridine and an excess of acetic anhydride is added. After 16 hours at room temperature, the solvent is evaporated and the residue is chromatographed on silica gel. 5- [2 '- (3 - [(3,4-dimethoxyphenylethyl) methylamino] propyl) -m-dithian-2'-yl] -2-methoxyphenyl acetate-1', 1 ', 3', 3'- tetraoxide in the form of a thick oil.

Analyse:Analysis:

Beregnet: C 55,56 H 6,39 N 2,40 Fundet: C 55,22 H 6,41 N 2,23.Calculated: C 55.56 H 6.39 N 2.40 Found: C 55.22 H 6.41 N 2.23.

Eksempel 14.Example 14.

Til 0,3 g N-methyl-3[2-(3,4-dimethoxyphenyl)-m-dithian-2-yl]propylamin--1,1,3,3-tetraoxid sættes 0,16 g 3,4-dimethoxy-Ø-phenylethylchlorid, 5 ml N,N-diisopropyl-N-ethylamin og 1,5 ml dimethylformamid, og der opvarmes i 16 timer ved 130°C. Opløsningen fordeles derefter mellem vand og ethylacetat. Remanensen chromatograferes på silicagel, hvorved fås N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2-(3,4-dimethoxyphen-yl)-m-dithian-2-yl]propylamin-l,1,3,3-tetraoxid med smeltepunkt 144°C (af methanol).To 0.3 g of N-methyl-3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propylamine - 1,1,3,3-tetraoxide is added 0.16 g of dimethoxy-β-phenylethyl chloride, 5 ml of N, N-diisopropyl-N-ethylamine and 1.5 ml of dimethylformamide and heated for 16 hours at 130 ° C. The solution is then partitioned between water and ethyl acetate. The residue is chromatographed on silica gel to give N- (3,4-dimethoxyphenylethyl) -N-methyl-3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propylamine-1,3 3-tetraoxide, m.p. 144 ° C (of methanol).

Den som udgangsmateriale anvendte N-methyl-3[2-(3,4-dimethoxyphenyl)--m-dithian-2-yl]propylamin-l,l,3,3-tetraoxid kan fremstilles på følgende måde: 3,95 g 2-(3-chlorpropyl)-2-(3,4-dimethoxyphenyl)-m-dithian-1,1,3,3--tetraoxid opløses i 50 ml dimethylformamid. Opløsningen afkøles til 148323 40 0°C, og der tilsættes 15 g methylamin. Der opvarmes i 18 timer ved 40eC under tryk. Opløsningen inddampes derefter, og krystalgrøden omkrystalliserés af en ringe mængde methanol. Der fås det ovenfor angivne produkt med smeltepunkt 164βC.The N-methyl-3 [2- (3,4-dimethoxyphenyl) - m -dithian-2-yl] propylamine-1,1,3,3-tetraoxide used as the starting material can be prepared as follows: 3.95 g 2- (3-Chloropropyl) -2- (3,4-dimethoxyphenyl) -m-dithian-1,1,3,3-tetraoxide is dissolved in 50 ml of dimethylformamide. The solution is cooled to 0 ° C and 15 g of methylamine are added. Heat for 18 hours at 40 ° C under pressure. The solution is then evaporated and the crystal crop is recrystallized from a small amount of methanol. The above product is obtained, m.p. 164βC.

Eksempel 15.Example 15

1 g H- (3,4-dimethoxyphenylethy1) -312-(3,4-dimethoxyphenyl) -m-dithian--2-yl]propylamin (fremstillet ifølge eksempel 9) opløses i 20 ml absolut pyridin, og der tilsættes 200 ml eddikesyreanhydrid. Efter 18 timers, forløb inddampes opløsningsmidlet, og remanensen fordeles mellem ether og natriumcarbonat (5%). Efter inddampning af opløsningsmidlet fås en olie (1,2 g), som opløses i 20 ml absolut tetrahydrofu-ran. Denne opløsning dryppes langsomt til en suspension af 0,4 g lithiumaluminiumhydrid og 20 ml absolut tetrahydrofuran. Til blandingen sættes langsomt en koncentreret vandig natriumsulfatopløsning, og blandingen filtreres. Efter inddampning af opløsningsmidlet fordeles remanensen mellem ether og vand, og de organiske ekstrakter oparbej des. Den olieagtige remanens behandles i acetone/ethylacetat med oxalsyre, hvorved N-(3,4-dimethoxyphenylethyl)-N-ethy1-3[2-(3,4-dimethoxyphenyl )-m-dithian-2-y1]propylamin-1,1,3,3-tetraoxidoxalat med smeltepunkt 126 - 127°C udkrystalliserer.1 g of H- (3,4-dimethoxyphenylethyl) -312- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propylamine (prepared according to Example 9) is dissolved in 20 ml of absolute pyridine and 200 ml is added. acetic anhydride. After 18 hours, the solvent was evaporated and the residue partitioned between ether and sodium carbonate (5%). After evaporation of the solvent, an oil (1.2 g) is dissolved in 20 ml of absolute tetrahydrofuran. This solution is slowly dripped to a suspension of 0.4 g of lithium aluminum hydride and 20 ml of absolute tetrahydrofuran. To the mixture is slowly added a concentrated aqueous sodium sulfate solution and the mixture is filtered. After evaporation of the solvent, the residue is partitioned between ether and water and the organic extracts are worked up. The oily residue is treated in acetone / ethyl acetate with oxalic acid to give N- (3,4-dimethoxyphenylethyl) -N-ethyl-3- [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propylamine-1, 1,3,3-tetraoxide oxalate, mp 126 - 127 ° C crystallizes.

Eksempel 16.Example 16.

1 g homoveratrumsyre opløses i 15 ml absolut tetrahydrofuran, og der tilsættes 0,15 g triethylamin. Ved en temperatur på 0 - 5°C tildryp-pes langsomt 0,72 g chlormyresyreisobutylester, og blandingen omrøres i 1 time ved 5 - 10°C. Derefter tildryppes en opløsning af 1,63 g N-methyl-3[2-(3,4-dimethoxyphenyl)-m-dithian-2-yl]propylamin (fremstillet ud fra 2-(γ-chlorpropyl)-2-(3,4-dimethoxyphenyl)-m-dithian og methylamin på analog måde som beskrevet i eksempel 14) i 5 ml tetrahydrofuran. Blandingen lades henstå natten over ved stuetemperatur. Efter inddampning af opløsningsmidlet fordeles remanensen mellem IN saltsyre og'ether. De organiske ekstrakter vaskes med 5%*s natriumcarbo-natopløsning og vand. Efter tørring med magnesiumsulfat inddampes opløsningsmidlet. Den olieagtige remanens (1,5 g) opløses i 15 ml tetra-Dissolve 1 g of homoveratrum acid in 15 ml of absolute tetrahydrofuran and add 0.15 g of triethylamine. At a temperature of 0-5 ° C, 0.72 g of chloromyric acid isobutyl ester is slowly added dropwise and the mixture is stirred for 1 hour at 5-10 ° C. Then a solution of 1.63 g of N-methyl-3 [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propylamine (prepared from 2- (γ-chloropropyl) -2- (3)) is added dropwise. 4-Dimethoxyphenyl) -m-dithian and methylamine in analogous manner as described in Example 14) in 5 ml of tetrahydrofuran. The mixture is allowed to stand overnight at room temperature. After evaporation of the solvent, the residue is partitioned between 1N hydrochloric acid and ether. The organic extracts are washed with 5% sodium carbonate solution and water. After drying with magnesium sulfate, the solvent is evaporated. The oily residue (1.5 g) is dissolved in 15 ml of tetrahydrocarbon.

Claims (5)

1A 8 3 2 3 hydrofuran og dryppes under tilbagesvaling under argon til en suspension af 0,15 g lithiumaluminiumhydrid. Blandingen koges i 2 timer, og der tilsættes derefter langsomt en koncentreret natriumsulfat-opløsning i vand og derefter 10 ml methylenchlorid. Blandingen filtreres , og opløsningen inddampes. Remanensen chromatograferes på silicagel, hvorved fås N-(3,4-dimethoxyphenylethyl)-N-methyl-3[2--(3,4-dimethoxyphenyl)-m-dithian-2-yl]propylamin i form af en tyk olie (jfr. eksempel 1).1A 8 3 2 3 hydrofuran and drip under reflux under argon to a suspension of 0.15 g of lithium aluminum hydride. The mixture is boiled for 2 hours and then a concentrated sodium sulfate solution is added slowly in water and then 10 ml of methylene chloride. The mixture is filtered and the solution is evaporated. The residue is chromatographed on silica gel to give N- (3,4-dimethoxyphenylethyl) -N-methyl-3- [2- (3,4-dimethoxyphenyl) -m-dithian-2-yl] propylamine in the form of a thick oil ( cf. example 1). 1. Analogifremgangsmåde til fremstilling af l,3-dithiolanyl(2)-eller 1,3-dithianyl(2)-forbindelser med den almene formel I /-<CH2>n\ i R5 R - I - hvor R betegner en gruppe med den almene formel a eller b R1 R3^“ eller Qb a b 12 3 hvor R , R og R hver betegner hydrogen, halogen, lavere alkyl, lavere alkoxy, benzyloxy, phenyl, nitro, trifluormethyl, hydroxy, cyano, di-lavere alkylamino eller lavere alkanoyloxy, eller to nabostillede grupper tilsammen betegner methylendioxy, ethylen- 4 dioxy eller butadien-l,3-ylen-l,4, R betegner hydrogen eller 5 6 7 lavere alkyl, R , R og R hver betegner hydrogen, halogen, lavere alkyl eller lavere alkoxy, eller to nabostillede grupper sammen betegner ethylendioxy, X betegner svovl, SO eller S02, Y betegner en ligekædet eller forgrenet, eventuelt hydroxysubstitueret ali-phatisk carbonhydridkæde med 2-5 carbonatomer, Z betegner en 148323 ligekædet eller forgrenet, eventuelt hydroxysubstitueret aliphatisk carbonhydridkæde med 1-4 carbonatomer, m betegner 0 eller 1, og n betegner 2 eller 3, hvorhos de som "lavere" betegnede grupper indeholder 1-6 carbonatomer, eller syreadditionssalte deraf, kendetegnet ved, at a) en forbindelse med den almene formel II /(CH2>n\ X X R C Η II hvor R, X og n hver har den ovenfor angivne betydning, omsættes med en forbindelse med den almene formel III R5 4 r r8 - Y - " - (Z)" VSi hvor R4 - R7, Y, Z og m hver har den ovenfor angivne betydning, O og R betegner en udtrædende gruppe, eller b) en forbindelse med den almene formel IV S f y=VH= “ -c -1 -" (z)" R7 4 7 hvor R, R - R , Y, Z og m hver har den ovenfor angivne betydning, omsættes med en forbindelse med den almene formel V HS - (CH„) - SH V λ n hvor n har den ovenfor angivne betydning, eller c) en forbindelse med den almene formel VI 148323 /(CH„) f 2'n' X X R - C Y - R8 VI Q hvor R, R , X, Y og n hver har den ovenfor angivne betydning, omsættes med en forbindelse med den almene formel VII «-»- <*>» R 4 7 hvor R - R , Z og m hver har den ovenfor angivne betydning, eller d) en forbindelse med den almene formel X / 2 \ r4 R - C - Y-N-H X 4 hvor R, R , X, Y og n hver har den ovenfor angivne betydning, omsættes med en forbindelse med den almene formel XI 5 8 hvor R - R , Z og m hver har den ovenfor angivne betydning, eller e) i en forbindelse med den almene formel XII eller XIII 4CH,)v R4 R5 ^ & » r' (ch2)\ r’4 / 2 n\ j R5 x x c=o I. β R - C - Y - N - (Z)m ^ XIII R7 4 7 148323 hvor R, R - R i X; Y; Z, m og n hver har den ovenfor angivne betydning, Y^ og Z1 hver betegner henholdsvis Y og Z eller en tilsvarende oxosubstitueret gruppe, idet mindst én af grupperne Y^ og Z dog indeholder én carbonylgruppe, og R' betegner et hydrogenatom eller en C1_5~alkylgruppe, reduceres carbonylgruppen, hvorefter en fremstillet forbindelse med den almene formel I, hvor X betegner et svovlatom, om ønsket oxideres til en forbindelse med den almene formel I, hvor X betegner SO eller SO-, en fremstillet 4 z forbindelse med den almene formel X, hvor R betegner hydrogen, om ønsket N-lavere alkyleres til en forbindelse med den almene formel 4 1. hvor R betegner C, --alkyl, en lavere alkoxy- eller benzyloxy- 1 2 3 gruppe for R , R eller R om ønsket omdannes til en hydroxygruppe, 12 3 en hydroxygruppe for R , R eller R om ønsket O-lavere alkyleres eller forestres med en lavere alkancarboxylsyre, og en vunden base om ønsket omdannes til et syreadditionssalt, hvorhos de som "lavere" betegnede grupper indeholder 1-6 carbonatomer.An analogous process for the preparation of 1,3-dithiolanyl (2) or 1,3-dithianyl (2) compounds of general formula I / - <CH2> n \ in R5 R - I - wherein R represents a group of the general formula a or b R 1 R 3 4 or Qb ab 12 3 wherein R, R and R each represent hydrogen, halogen, lower alkyl, lower alkoxy, benzyloxy, phenyl, nitro, trifluoromethyl, hydroxy, cyano, di-lower alkylamino lower alkanoyloxy, or two adjacent groups together represent methylenedioxy, ethylene-4-dioxy or butadiene-1,3-ylene-1,4, R represents hydrogen or lower alkyl, R, R and R each represent hydrogen, halogen, lower alkyl or lower alkoxy, or two adjacent groups together represent ethylenedioxy, X represents sulfur, SO or SO 2 aliphatic hydrocarbon chain having 1-4 carbon atoms, m represents 0 or 1 and n represents 2 or 3 wherein the "lower" groups contain 1-6 carbon atoms, or acid addition salts thereof, characterized in that a) a compound of the general formula II / (CH 2> n XXRC Η II wherein R, X and n each have the meaning given above are reacted with a compound of general formula III R5 4 r r8 - Y - "- (Z)" VSi where R4 - R7, Y, Z and m are each has the meaning given above, O and R represent a leaving group, or b) a compound of the general formula IV S f = V H = "-c -1 -" (z) "R 7 4 7 where R, R - R, Y, Z and m each have the meaning given above, are reacted with a compound of the general formula V HS - (CH₂) - SH V λ n where n has the meaning given above, or c) a compound of the general formula VI 148323 / (CH2) f 2'N 'XXR - CY - R8 VI Q wherein R, R, X, Y and n each have the meaning given above are reacted with a compound of the general formula VII' - '- <* > »R 4 7 where R - R, Z and m each have the meaning given above, or d) a compound of the general formula X / 2 \ R 4 R - C - YNH X 4 wherein R, R, X, Y and n each have the meaning given above. , is reacted with a compound of general formula XI 5 8 wherein R - R, Z and m are each as defined above, or e) in a compound of general formula XII or XIII 4CH, '(ch2) \ r'4 / 2 n \ j R5 xxc = o I. β R - C - Y - N - (Z) m ^ XIII R7 4 7 148323 where R, R - R in X; Y; Z, m and n each have the meaning given above, Y 1 and Z 1 each represent Y and Z respectively or a corresponding oxo-substituted group, however, at least one of the groups Y 1 and Z contains one carbonyl group and R 1 represents a hydrogen atom or a C1-5 alkyl group, the carbonyl group is reduced, whereupon a compound of general formula I wherein X represents a sulfur atom is optionally oxidized to a compound of general formula I where X represents SO or SO-, a prepared 4 z compound having the general formula X, wherein R represents hydrogen, if desired, N-lower is alkylated to a compound of general formula 4 1. wherein R represents C1-6 alkyl, a lower alkoxy or benzyloxy group for R, R or R if desired is converted to a hydroxy group, 12 is a hydroxy group for R, R or R if desired is O-lower alkylated or esterified with a lower alkane carboxylic acid, and a recovered base if desired is converted to an acid addition salt, wherein they are designated as "lower" group are containing 1-6 carbon atoms. 2. Fremgangsmåde ifølge krav 1, kendetegnet ved, at der fremstilles N-(3,4-dimethoxy-phenylethyl) -N-methyl-3 [2- (p-methoxyphenyl) -m-dithian-2-yl] prop-ylamin eller et syreadditionssalt deraf.Process according to claim 1, characterized in that N- (3,4-dimethoxy-phenylethyl) -N-methyl-3 [2- (p-methoxyphenyl) -m-dithian-2-yl] propylamine or an acid addition salt thereof. 3. Fremgangsmåde ifølge krav 1, kendetegnet ved, at der fremstilles N-(3,4-dimethoxy-phenylethyl)-N-methyl-3[2-phenyl-m-dithian-2-yl]propylamin eller et syreadditionssalt deraf.Process according to claim 1, characterized in that N- (3,4-dimethoxy-phenylethyl) -N-methyl-3 [2-phenyl-m-dithian-2-yl] propylamine or an acid addition salt thereof is prepared. 4. Fremgangsmåde ifølge krav 1, kendetegnet ved, at der fremstilles N-(p-chlorphenyl-ethyl)-N-methyl-3[2-phenyl-m-dithian-2-yl]propylamin eller et syreadditionssalt deraf.Process according to claim 1, characterized in that N- (p-chlorophenyl-ethyl) -N-methyl-3 [2-phenyl-m-dithian-2-yl] propylamine or an acid addition salt thereof is prepared. 5. Fremgangsmåde ifølge krav 1, kendetegnet ved, at der fremstilles N-(3,4-dimethoxy-phenylethyl)-N-methyl-3[2-(2-naphthyl)-m-dithian-2-yl]propylamin eller et syreadditionssalt deraf.Process according to claim 1, characterized in that N- (3,4-dimethoxy-phenylethyl) -N-methyl-3 [2- (2-naphthyl) -m-dithian-2-yl] propylamine or a acid addition salt thereof.
DK668174A 1973-12-21 1974-12-19 ANALOGY PROCEDURE FOR PREPARING 1,3-DITHIOLANYL (2) - OR 1,3-DITHIANYL (2) COMPOUNDS DK148323C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK11179A DK150486C (en) 1973-12-21 1979-01-10 1,3-DITHIOLANYL (2) - OR 1,3-DITHIANYL (2) COMPOUNDS FOR USING INTERMEDIATES IN THE PREPARATION OF PHARMACOLOGICAL ACTIVE OTHER 1,3-DITHIOLANYL (2) - OR 1,3-DITHIANYL (2) -OREL

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1803073 1973-12-21
CH1803073A CH611614A5 (en) 1973-12-21 1973-12-21 Process for the preparation of heterocyclic compounds

Publications (3)

Publication Number Publication Date
DK668174A DK668174A (en) 1975-08-25
DK148323B true DK148323B (en) 1985-06-10
DK148323C DK148323C (en) 1986-03-03

Family

ID=4429892

Family Applications (1)

Application Number Title Priority Date Filing Date
DK668174A DK148323C (en) 1973-12-21 1974-12-19 ANALOGY PROCEDURE FOR PREPARING 1,3-DITHIOLANYL (2) - OR 1,3-DITHIANYL (2) COMPOUNDS

Country Status (24)

Country Link
JP (1) JPS595594B2 (en)
AT (5) AT344693B (en)
AU (1) AU511714B2 (en)
BE (1) BE823625A (en)
CA (4) CA1057295A (en)
CH (3) CH611614A5 (en)
DD (1) DD116829A5 (en)
DE (2) DE2463173C2 (en)
DK (1) DK148323C (en)
ES (5) ES433172A1 (en)
FI (1) FI67216C (en)
FR (1) FR2255064B1 (en)
GB (3) GB1489088A (en)
HK (1) HK43380A (en)
HU (1) HU170429B (en)
IE (1) IE40788B1 (en)
IL (3) IL46146A (en)
LU (1) LU71530A1 (en)
NL (1) NL158496B (en)
NO (1) NO142669C (en)
PH (3) PH19393A (en)
SE (2) SE415763B (en)
YU (1) YU39311B (en)
ZA (1) ZA747526B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515173A1 (en) * 1981-10-28 1983-04-29 Delalande Sa 3-Methoxy 4-alkoxy benzaldehyde(s) - useful as intermediates for antibacterials, esp. trimethoprim and tetroxoprim
JPS60142297U (en) * 1984-02-29 1985-09-20 株式会社豊田自動織機製作所 Rotating device for swiveling driver's seat in forklift
JPS62171328U (en) * 1986-04-23 1987-10-30
DE3642331A1 (en) * 1986-12-11 1988-06-23 Basf Ag BASICLY SUBSTITUTED PHENYL ACETONITRILES, THEIR PRODUCTION AND THE MEDICINAL PRODUCTS CONTAINING THEM
US5434179A (en) * 1989-06-06 1995-07-18 Takeda Chemical Industries, Ltd. Method for improving brain function using cholinesterase-inhibiting aminoketone compounds
MXPA04006344A (en) * 2001-12-28 2005-03-31 Takeda Pharmaceutical Preventives/remedies for urinary disturbance.
WO2010006103A1 (en) * 2008-07-10 2010-01-14 Ore Pharmaceuticals Inc. Method for enhancing cognition or inhibiting cognitive decline

Also Published As

Publication number Publication date
DE2463173C2 (en) 1987-01-29
IL52843A0 (en) 1977-10-31
GB1489086A (en) 1977-10-19
PH13396A (en) 1980-03-28
CH611614A5 (en) 1979-06-15
HK43380A (en) 1980-08-22
CA1079290A (en) 1980-06-10
IE40788L (en) 1975-06-21
CA1072966A (en) 1980-03-04
SE434746B (en) 1984-08-13
AT350053B (en) 1979-05-10
ES451137A1 (en) 1977-08-16
NL7416507A (en) 1975-06-24
ES451135A1 (en) 1977-08-16
DE2460593A1 (en) 1975-07-03
ZA747526B (en) 1975-12-31
GB1489088A (en) 1977-10-19
ES451136A1 (en) 1977-10-01
ATA38778A (en) 1978-08-15
YU39311B (en) 1984-10-31
DD116829A5 (en) 1975-12-12
NO744615L (en) 1975-07-21
HU170429B (en) 1977-06-28
DE2460593C3 (en) 1979-09-13
FR2255064B1 (en) 1978-03-24
ES451134A1 (en) 1977-08-16
IL52844A0 (en) 1977-10-31
PH13326A (en) 1980-03-13
DK668174A (en) 1975-08-25
AU7600874A (en) 1976-06-03
DE2460593B2 (en) 1979-01-18
FR2255064A1 (en) 1975-07-18
AT344693B (en) 1978-08-10
CA1057295A (en) 1979-06-26
FI352774A (en) 1975-06-22
ATA39178A (en) 1978-08-15
PH19393A (en) 1986-04-07
NO142669B (en) 1980-06-16
BE823625A (en) 1975-06-20
YU336874A (en) 1982-05-31
AU511714B2 (en) 1980-09-04
IE40788B1 (en) 1979-08-15
IL46146A (en) 1980-09-16
NO142669C (en) 1980-09-24
FI67216C (en) 1985-02-11
DK148323C (en) 1986-03-03
ATA38878A (en) 1978-08-15
JPS5095267A (en) 1975-07-29
AT349013B (en) 1979-03-12
AT349014B (en) 1979-03-12
NL158496B (en) 1978-11-15
SE415763B (en) 1980-10-27
GB1489087A (en) 1977-10-19
AT349012B (en) 1979-03-12
AU3224278A (en) 1978-05-25
CH620921A5 (en) 1980-12-31
JPS595594B2 (en) 1984-02-06
FI67216B (en) 1984-10-31
SE7416086L (en) 1975-06-23
IL46146A0 (en) 1975-03-13
ATA38978A (en) 1978-10-15
ATA1022674A (en) 1977-12-15
LU71530A1 (en) 1976-11-11
CA1086320A (en) 1980-09-23
CH620920A5 (en) 1980-12-31
ES433172A1 (en) 1977-04-16

Similar Documents

Publication Publication Date Title
SU1424730A3 (en) Method of producing methylsulfonamidophenylalkyl amines and their pharmaceutically acceptable salts
DK169331B1 (en) Process for Preparation of Optically Active R (+) - Carbazole Derivatives, New R (+) - Carbazole Derivatives, and Drugs Containing These Compounds
FI83770C (en) FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA ACYLANILIDER.
FI77839B (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA THERAPEUTIC EFFECTIVE TRIPHENYLALKAN- OCH ALKENDERIVAT.
IE50862B1 (en) Sulfamoyl-substituted phenethylamine derivatives,their preparation and pharmaceutical compositions containing them
IL200217A (en) Dihydrotriazine derivatives, compositions thereof and use thereof in the preparation of medicaments
JP3732858B2 (en) N- (3-amino-2-hydroxybutyl) sulfonamide derivatives as HIV protease inhibitors
US4005141A (en) Perfluoroalkylsulfonamidoaryl compounds
JPH0253762A (en) Novel sulfonamide, and metabolic function disease and circulation disorder treatment drug containing the same
CZ20013176A3 (en) Compound producing metalloproteinase inhibitor, pharmaceutical preparation, and process for preparing thereof and a medicament
DK148323B (en) ANALOGY PROCEDURE FOR PREPARING 1,3-DITHIOLANYL (2) - OR 1,3-DITHIANYL (2) COMPOUNDS
DK146386B (en) METHOD OF ANALOGUE FOR THE PREPARATION OR SALTS OF PHENYL ALKANOLAMINE COMPOUNDS
NZ242626A (en) Substituted carboxylic acid derivatives, preparation and pharmaceutical compositions thereof
US3906024A (en) Perfluoroalkanesulfonamidoaryl compounds
PT984000E (en) Process for producing amide derivatives and intermediate compounds
PH26828A (en) Benzonitrile derivatives pharmaceutical preparations and use thereof
US3574749A (en) 1-(4-amidophenoxy)-3-amino-2-propanol derivatives
US4073797A (en) Sulphur containing derivatives
CS208486B2 (en) Method of making the new derivatives of the alcanolamines
US4164412A (en) Perfluoroalkylsulfonamidoaryl compounds
SK59096A3 (en) Benzoylguanidine derivative containing fluor, preparation method thereof and pharmaceutical composition containing them
US4127588A (en) Sulphur containing derivatives
KR790001382B1 (en) Process for preparing of containing heterocyclic compounds
US4831028A (en) Novel benzothiazinone derivatives, processes for their preparation, medicaments containing them and their use
JPH0567619B2 (en)

Legal Events

Date Code Title Description
PBP Patent lapsed